All articles1000

Emotional support after cancer: What works for young adults?
Educational guidance sessions and video-based group music therapy show promise in addressing the emotional strain and identity shifts faced by young cancer patients.

The hidden dangers in chemical hair relaxers your patients need to know
Chemical hair relaxers are linked to increased risks of uterine fibroids, endometriosis, and certain cancers. Clinicians should counsel patients on these potential dangers.

Pluvicto's expanded approval: What it means for advanced prostate cancer
The FDA expanded Pluvicto's approval for PSMA-positive metastatic castration-resistant prostate cancer, making it available earlier in the treatment sequence.

Gene dosage imbalance drives systemic metabolic dysfunction in Down syndrome
An extra copy of human chromosome 21 orthologs disrupts systemic metabolism in a Down syndrome mouse model, causing insulin resistance and dyslipidemia.

Pupil Dilation: A Window into Synesthesia's Perceptual Quality
Pupil size changes reflect the vividness and automaticity of synesthetic experiences, offering an objective measure of subjective perception.

Coffee may cut liver disease risk, related mortality
Regular coffee consumption correlates with a reduced risk of chronic liver disease and associated mortality, according to UK Biobank data.
Michigan reports two deaths in cyclosporiasis outbreak, raising public health concerns
Michigan public health officials confirm two deaths linked to a cyclosporiasis outbreak, highlighting the severity of this parasitic infection.

Very low nicotine cigarettes do not increase daily smoking
Using very low nicotine content cigarettes does not lead to an increase in the daily number of cigarettes smoked, according to recent research.

Oral antibiotics match IV for severe pediatric pneumonia
Oral antibiotics demonstrate non-inferiority to intravenous regimens for severe community-acquired bacterial pneumonia in children, challenging traditional treatment paradigms.

GLP-1s reduce inflammation in adults without diabetes
GLP-1 receptor agonists lower C-reactive protein levels in adults without diabetes, indicating a potential anti-inflammatory effect beyond glucose control.

Safe caffeine intake does not harm heart health
Established guidelines for safe caffeine intake do not pose a risk to cardiovascular health, despite the expanding market of caffeine-containing products.

Dialysis patients face escalating medication burden over two decades
The number of medications prescribed to dialysis patients has steadily increased since 2003, raising concerns about polypharmacy and adverse drug events.

Biomarkers hint at who recovers motor function after stroke
An exploratory substudy of the PRACTISE trial identified specific biomarkers linked to upper-extremity motor recovery after stroke, including neuroplasticity and inflammatory markers.

Beyond screen time: How short videos rewire dopamine pathways
The pervasive use of short-form video content raises questions about its impact on attention spans and cognitive processing, particularly in younger populations.
Ponatinib: Efficacy vs. vascular risk, 10 years on
Ten years of real-world data confirm ponatinib's efficacy in CML and Ph+ ALL, but highlight persistent vascular occlusive event risks despite risk-management measures.
Part-Time Pay: Can Doctors Really Work Less and Thrive?
Many physicians are exploring part-time work arrangements to improve work-life balance, challenging traditional full-time expectations in medicine.

A Simpler Score for Coronary Calcium: Does it Help Predict Risk?
A simplified risk score may predict coronary artery calcium on CTA, potentially streamlining risk assessment for cardiovascular disease.
Shorter octreotide could ease variceal bleed burden for your patients
The optimal duration of octreotide infusion for acute esophageal variceal bleeding has been a subject of debate, with current guidelines recommending a 2-5 day course.
Chiglitazar: Is a 'pan' approach better for MASLD?
Chiglitazar, a PPAR pan-agonist, significantly reduced liver fat content and improved insulin sensitivity in MASLD patients with hypertriglyceridemia.

Fibromyalgia: Is the pain all in the genes?
A large-scale genetic study has identified specific genetic variants associated with fibromyalgia, offering new insights into its biological basis.

Your chronic GI patients: Don't overlook this key dietary history detail
A physician's prolonged suffering from severe gastrointestinal distress stemmed from a surprising, self-imposed dietary choice, highlighting the complexities of patient adherence.

Prior Authorization: Why 'Fighting Back' Is Now Standard Practice
Navigating prior authorization is a significant burden for clinicians, often requiring multiple appeals to secure necessary patient care.
Why PARP inhibitors are changing the mCRPC treatment algorithm
PARP inhibitors are emerging as a targeted therapy for prostate cancer, particularly in patients with specific genetic mutations. Understanding their role is crucial for treatment selection.

Isatuximab quadruplet deepens myeloma response, but for how long?
Isatuximab, bortezomib, lenalidomide, and dexamethasone quadruplet therapy achieved higher rates of MRD negativity and prolonged time to progression in transplant-ineligible multiple myeloma.

Can circulating metabolites clear senescent cells in TMJ-OA?
Autologous circulating extracellular vesicles (C-EVs) significantly enhanced condylar bone regeneration and alleviated symptoms in TMJ-OA patients, targeting senescent chondrocytes.

Cyclobenzaprine targets fibromyalgia pain by improving sleep
Bedtime sublingual cyclobenzaprine 5.6 mg significantly reduced daily pain in fibromyalgia patients by targeting nonrestorative sleep, a Phase 3 trial showed.

Lebrikizumab maintains atopic dermatitis remission for months off-therapy
Lebrikizumab monotherapy sustained deep remission in atopic dermatitis patients for up to 38 weeks after treatment cessation.

TNF emerges as a key node in autoimmune hepatitis, trial shows
An integrative omics approach identified TNF as a central pathogenic driver in autoimmune hepatitis, with a phase IIa trial validating TNF inhibition.

Iptacopan's 24-month IgA nephropathy data: a new standard of care?
Iptacopan significantly reduced proteinuria by 38.3% over 24 months in IgA nephropathy patients, offering a new therapeutic option.

Setmelanotide curbs insatiable hunger in acquired hypothalamic obesity
Setmelanotide significantly improved body mass index, hunger, and hyperphagia symptoms in patients with acquired hypothalamic obesity, according to the TRANSCEND trial.
The Neutropenic Diet: An Unnecessary Burden for Leukemia and Transplant Patients?
A liberalized diet was noninferior to the traditional neutropenic diet for preventing major infections in patients with acute leukemia or undergoing stem-cell transplant.

RNR inhibition reverses FLT3i resistance in AML, prolonging survival
Ribonucleotide reductase (RNR) inhibition restores FLT3 inhibitor sensitivity in FLT3 ITD+ AML with NRAS mutations, significantly prolonging survival in xenograft models.
Ecopipam for Tourette Syndrome: Did it deliver on its promise?
Ecopipam significantly reduced tic severity in Tourette syndrome patients, but its safety profile warrants careful consideration for long-term use.
The Oral-Systemic Link: How Gut Dysbiosis Connects RA and Periodontitis
Subgingival microbial dysbiosis acts as a pathophysiological link between rheumatoid arthritis and periodontitis, driving systemic inflammation, according to a new review.

Asciminib: A new first-line option for chronic myeloid leukemia?
Asciminib demonstrated superior efficacy and a favorable safety profile compared to investigator-selected TKIs in newly diagnosed chronic myeloid leukemia.

Interrupting immunomodulators for infection: a strategy without evidence?
Temporarily stopping immunomodulatory agents during infection in inflammatory rheumatic disease patients did not reduce severe infection or treatment failure compared to continuation.

Delegating tasks to medical assistants: What can GPs safely offload?
GPs often face challenges in workload management. Delegating specific clinical and administrative tasks to medical assistants can improve practice efficiency and patient access.

Cholecystectomy: The definitive answer to recurrent gallstone pancreatitis?
Early cholecystectomy significantly reduces recurrent gallstone pancreatitis, aligning with guidelines often overlooked in real-world practice.

The Unseen Burden of Kidney Transplant Failure
Kidney transplant failure extends beyond medical complications, imposing profound psychological and social burdens on patients and their care partners.

CGM offers tighter glucose control for type 2 diabetes on dialysis
Continuous glucose monitoring (CGM) improves glycemic control in patients with type 2 diabetes undergoing hemodialysis, a population often overlooked in diabetes management.

Kidney transplant process sees shifts, but disparities persist
A recent report on European kidney transplantation highlights evolving donor types and recipient demographics, but persistent inequities in access remain.

Weekly growth hormone therapy: a safer path to long-term height gains?
Weekly growth hormone therapy offers a potential alternative to daily injections, improving long-term height outcomes in children with growth hormone deficiency.
EHR data flags liver transplant patients at highest risk of post-op complications
An EHR-based marker identifies liver transplant recipients at high risk for adverse post-transplant outcomes, offering a tool for early intervention and personalised care strategies.

GLP-1s and lifestyle: a new path to stronger bones?
Combining GLP-1 receptor agonists with lifestyle interventions may offer benefits for bone mineral density, particularly in patients with obesity.

Your obesity patients deserve more than just weight loss goals
Modern obesity treatment is shifting focus from simple weight loss to more meaningful clinical endpoints, reflecting a broader understanding of the disease's impact.

The long shadow of head trauma: sport, CTE, and dementia risk
Repeated head impacts in contact sports significantly increase the risk of neurodegenerative diseases, including dementia and chronic traumatic encephalopathy (CTE).

NHS waiting lists shorten, but regional disparities persist for patients
NHS waiting lists are finally shrinking across England, but access to timely care remains uneven, with some regions seeing little improvement.

EMA and EISMEA streamline health innovation: Will it cut red tape?
The European Medicines Agency (EMA) and the European Innovation Council and SMEs Executive Agency (EISMEA) have formalized cooperation to accelerate health innovation. This aims to simplify regulatory pathways for emerging health technologies.

Metastatic pancreatic cancer: A new drug could shift your approach
The EMA granted accelerated assessment for an investigational medicine for metastatic pancreatic adenocarcinoma, potentially offering a new option in a difficult disease.

EMA targets women's health: Will it close the evidence gap?
The European Medicines Agency (EMA) has intensified efforts to address the persistent evidence gap in women's health, aiming to improve medicine development and access.

EHR-derived marker flags liver transplant recipients at high risk of early death
An EHR-based marker identifies liver transplant recipients at increased risk of 90-day mortality, offering a tool for pre-transplant risk stratification and post-operative management.

IgA nephritis in older transplant patients: a data desert for optimal care
Optimal management of IgA nephritis in older, post-transplant patients remains poorly defined due to a critical lack of dedicated research.

Why changing clinical practices demands a new kind of trust
The evolving landscape of medical practice, driven by new evidence and technologies, fundamentally reshapes the clinician-patient trust dynamic.

World Cup Injuries: A Stress Test for Sports Medicine
The recent World Cup highlighted the intense physical demands on elite athletes, with a high incidence of muscle and joint injuries challenging current sports medicine practices.

Medical mistrust isn't just historical. It's political
The convergence of medical mistrust, the wellness industry, and political ideologies creates a complex challenge for healthcare, eroding public health efforts and patient adherence.

The real reason joint oncology practices need explicit protocols
Running a joint oncology clinic presents unique challenges and benefits, requiring careful navigation of professional boundaries and patient dynamics.

Prenatal alcohol exposure: Why 'no amount is safe' isn't enough
Despite clear guidelines, a significant number of pregnant women continue to consume alcohol, raising concerns about fetal alcohol spectrum disorders.

AI won't replace doctors, but it might erode your core skills
The increasing reliance on AI in medicine raises concerns about the erosion of fundamental clinical skills among healthcare professionals.

Integrating Medical Cannabis in Geriatric Primary Care: A Viable Path?
Integrating medical cannabis clinics into geriatric primary care practices shows promise for managing chronic conditions in older adults.

Medical Training's New Perfectionism: A Silent Epidemic Among Future Clinicians
Medical trainees face unprecedented pressure for perfection, leading to burnout and mental health crises, impacting patient care and workforce retention.

The real reason AI is reshaping clinical skill acquisition
Artificial intelligence tools are reshaping medical education, offering new avenues for learning but also raising questions about clinical reasoning development.

Lymphatic malformations: Is your management approach outdated?
Lymphatic malformations, particularly cystic hygromas, demand a nuanced management approach, balancing observation with targeted interventions.
How lipid packing dictates caveolae stability at the plasma membrane
Lipid packing density plays a critical role in confining caveolae to the plasma membrane, influencing their stability and function in cellular processes.

ARHGAP36: A new survival predictor for neuroblastoma patients
High ARHGAP36 levels predict improved 5-year survival in neuroblastoma patients, linking FOXC1-induced expression to altered Hedgehog signaling.
Enhancer activity: The indirect chromatin modulation that reshapes gene expression
Ligand-dependent enhancer activation indirectly influences non-target promoters within the same chromatin domain, revealing a complex regulatory mechanism.

New CRISPR screen identifies key regulators of anterior neural tube closure
A novel CRISPR interference screen in human organoids identified ZIC2, SOX11, and ZNF521 as essential transcription factors governing anterior neural tube closure.

Infants move to music, but coordinated rhythm takes a year to emerge
Infants exhibit enhanced auditory responses to music from 3 months, but complex, structured movement patterns to music only emerge by 12 months.

Prime editing in zebrafish: a precise path to gene modification?
Prime editing, a refined CRISPR/Cas9 technology, enables precise DNA insertions and substitutions in zebrafish, with nuclease-based PEn achieving up to 27.3% precise insertion.

When ribosomes pause at stop codons, protein integrity hangs in the balance
Ribosome pausing at stop codons varies by sequence and tissue, influencing protein C-terminal integrity and potentially leading to heterogeneous protein extensions.

Early word recognition: a skill, not just a vocabulary count
Word recognition in early childhood is a skill that develops continuously, becoming faster and more accurate, and is deeply intertwined with vocabulary growth.

Proline Hydroxylation: A New Target for RNA Metabolism and Cell Cycle Regulation?
A new workflow combining HILIC and LC-MS identified thousands of proline hydroxylation sites, revealing roles in RNA metabolism and cell cycle regulation.

Pandemic PPE: Billions spent, but healthcare wasn't safer
Government failures in PPE procurement and distribution during the COVID-19 pandemic left healthcare workers and patients at unacceptable risk.

Why air travel leaves clinicians feeling unwell and what causes it
Air travel subjects the human body to a complex array of physiological stressors, from hypoxia to altered circadian rhythms, impacting multiple organ systems.

Why useful medical content gets lost in the social media numbers game
Clinically relevant medical content struggles for visibility online, often overshadowed by less rigorous but more engaging posts, hindering knowledge dissemination.

The Benadryl Challenge: Why public health officials are struggling to stop this deadly trend
Public health officials are deploying multi-pronged strategies to combat the Benadryl Challenge, a viral social media trend linked to severe diphenhydramine toxicity and fatalities.

NHS waiting lists shorten, but regional disparities persist
NHS waiting lists are decreasing nationally, but access to timely care remains uneven across England, creating a postcode lottery for patients.

Repeated head impacts: What they mean for dementia risk
Repeated blows to the head in contact sports significantly increase the risk of dementia, particularly in former professional athletes.

Why are medical schools failing to teach clinicians about autism?
Many medical schools across Europe lack essential education on autism, leaving future clinicians unprepared to diagnose and manage autistic patients.

Why Autism 'Unmasking' in Girls Demands a New Clinical Lens
Autism 'unmasking' in girls, often triggered by life transitions, reveals previously hidden autistic traits, necessitating a re-evaluation of diagnostic criteria and clinical support.

Reformer Pilates: The Hype, The Hope, and The Hard Data Gap
Reformer Pilates enjoys widespread popularity for musculoskeletal health, but robust clinical evidence supporting its specific efficacy remains limited.

Why prescribed cannabis isn't safer for adolescent brains
Medical cannabis use in adolescents carries significant risks, including psychiatric disorders and impaired neurodevelopment, demanding careful clinical consideration.

Do You Speak Medicine? Decoding Obscure Medical Terms
Medical jargon often obscures meaning, even for seasoned clinicians. Understanding the nuances of 'speaking medicine' is essential for precise communication.

Harlequin Ichthyosis: Understanding the Genetic Basis of a Rare Skin Disorder
Harlequin ichthyosis, a severe congenital skin disorder, stems from mutations in the ABCA12 gene, disrupting lipid transport and epidermal barrier function.

Ceftriaxone: Navigating Dosing, Indications, and Adverse Effects in Practice
Ceftriaxone, a third-generation cephalosporin, requires careful consideration of dosing, indications, and potential adverse effects for optimal patient outcomes.

Medical student debt vs. specialty pay: Can passion still win?
A look at average annual salaries for the most-searched medical specialties reveals significant variation, with surgical fields generally commanding higher compensation.

Heart Failure Treatment in 2026: A Clinical Overview
Heart failure management has changed substantially over the past decade. This clinical overview covers the four pillars of guideline-directed medical therapy, the role of device therapy, and emerging treatments entering practice in 2026.

What Is CAR-T Cell Therapy? Mechanism, Approved Indications, and Key Evidence
CAR-T cell therapy reprogrammes a patient's own T cells to seek and destroy cancer cells. Here is what clinicians need to know about how it works, which cancers it is approved for, and what the evidence shows.

What Is an SGLT2 Inhibitor? Mechanism, Indications, and Evidence
SGLT2 inhibitors block renal glucose reabsorption to lower blood sugar and protect the heart and kidneys. A clinical primer on mechanism, approved agents, key trial evidence, and safety.

Infrared saunas for workout recovery: still more hype than help?
Evidence for infrared saunas improving workout recovery remains limited and inconsistent, with studies showing mixed results on muscle soreness and performance.

Fake medicines: How to spot substandard drugs and protect your patients
One in ten medicines globally is estimated to be fake or substandard, posing significant health risks. Clinicians must verify drug sources and educate patients.

Chronic Migraine: Is the Gut-Brain Axis the Missing Link?
Chronic migraine frequently co-occurs with gastrointestinal issues, suggesting a gut-brain axis involvement through dysbiosis and inflammation.

Why lifestyle advice alone still dominates obesity searches
Despite advances in pharmacotherapy, Google searches for obesity management remain heavily skewed towards lifestyle interventions, indicating a persistent public perception.

Why clinician wellness is not a luxury, but a bedrock of patient care
Clinician well-being directly impacts patient outcomes, with recent research emphasizing holistic approaches to care and engagement.

Jideytro offers new hope for ROS1-positive NSCLC after prior therapy
The FDA approved Jideytro for previously treated ROS1-positive non-small cell lung cancer, providing a new option for this rare subtype.
Does dupilumab increase lymphoma risk in eczema patients?
Dupilumab, a common eczema treatment, has raised questions about its potential link to lymphoma. Data suggests no increased risk, but vigilance remains key.

Molecular Profiling Refines Salivary Gland Tumor Diagnosis
Molecular profiling improves the diagnostic accuracy and identification of actionable alterations in complex salivary gland tumors, complementing traditional histopathology.

Could a monoclonal antibody finally tackle ARDS?
ALT-100, a novel monoclonal antibody, shows potential in mitigating acute respiratory distress syndrome, targeting inflammatory pathways to improve patient outcomes.

WHO outlines seven strategies to prevent drowning deaths
The World Health Organization launched seven evidence-based strategies to reduce drowning, a leading cause of unintentional injury death globally. These interventions target both individual and community-level risks.

Bundibugyo virus: Why community trust is the only vaccine we have
Effective community engagement is critical for containing Bundibugyo virus outbreaks, according to new WHO operational guidance.

Missing early psoriatic arthritis means irreversible joint damage
A new model incorporating the Psoriasis Epidemiology Screening Tool (PEST) may identify psoriasis patients at higher risk for developing psoriatic arthritis.
Patellofemoral anatomy may predict cartilage damage in OA
Specific patellofemoral joint anatomical features correlate with the location and severity of cartilage damage in osteoarthritis, offering a potential predictive tool.
Frailty, not just RA, predicts osteoporotic fracture risk
Frailty significantly increases the risk of osteoporotic fractures in veterans with rheumatoid arthritis, independent of traditional risk factors.

Enpatoran gets breakthrough tag for lupus: Another IFN-I inhibitor enters the fray
The FDA granted breakthrough designation to enpatoran for systemic lupus erythematosus, signaling a potential new option targeting type I interferon.

Avacopan study retracted: What it means for ANCA vasculitis efficacy
The New England Journal of Medicine retracted a key avacopan study, raising questions about the FDA's efficacy assessment for ANCA-associated vasculitis.

Smartphones and Pacemakers: Separating Fact from Electromagnetic Fiction
Modern smartphones pose minimal risk of electromagnetic interference with pacemakers and ICDs, provided a safe distance is maintained.

Cardiovascular risk: Why men die earlier, women live sicker
Cardiovascular risk factors impact longevity and morbidity differently by sex, with men experiencing earlier mortality and women facing a longer duration of disease.

Severe VT in ischaemic cardiomyopathy: Why current care isn't enough
A case of sustained ventricular tachycardia in ischaemic cardiomyopathy highlights the complexities of managing severe left ventricular systolic dysfunction.

Pulsed Field Ablation: A New Frontier for Atrial Fibrillation?
Pulsed field ablation offers a novel, non-thermal approach to cardiac tissue destruction, leveraging irreversible electroporation for targeted cell death in arrhythmias.

For atrial fibrillation, integrated pathways may beat individual fixes
The AF-CARE pathway, a comprehensive, integrated management strategy, aims to improve outcomes for atrial fibrillation patients by standardising care.

Why cardiac amyloidosis diagnoses are surging and what it means for GPs
Cardiac amyloidosis diagnoses are increasing due to improved awareness and advanced imaging, revealing a previously underrecognized cause of heart failure.

AI in the ED: Can algorithms truly accelerate acute cardiac care?
Artificial intelligence tools show promise in improving diagnostic speed and accuracy for acute cardiac conditions, but integration challenges persist.

Vapes and Snus: What the ESC Says About Cardiovascular Risk
The European Society of Cardiology has clarified its position on electronic cigarettes and snus, outlining distinct cardiovascular risks.

AFib ablation: Stop assuming success based on AFib type alone
Catheter ablation effectively reduces atrial fibrillation recurrence, but patient selection is key to maximising long-term success and symptom improvement.

LVADs boost survival, but our metrics miss the real success story.
Left ventricular assist devices (LVADs) offer a lifeline for advanced heart failure, but their utility hinges on precise patient selection and clear outcome metrics.

A flu shot may shield your patients from new AFib
Influenza infection significantly increases the risk of new-onset atrial fibrillation, particularly in older adults and those with pre-existing cardiovascular conditions.

How will AI change your daily cardiology workflow by 2026?
The ESC Digital and AI Summit 2026 in Basel will showcase advancements in AI-driven diagnostics and digital health tools for cardiovascular care.

Pulsed Field Ablation for VT/PVCs: The safer path, or just a new frontier?
Pulsed field ablation shows feasibility for ventricular tachycardia and premature ventricular complexes, extending its utility beyond atrial fibrillation.

AF-CARE Pathway: New ESC Guidelines Streamline AFib Management
The 2024 ESC AFib Guidelines introduce the AF-CARE pathway, emphasizing early diagnosis, comprehensive risk factor management, and integrated care.

Think cardiotoxicity is old news? Modern cancer therapy says otherwise
Cardiotoxicity from cancer treatments demands vigilant monitoring and proactive management, especially with immune checkpoint inhibitors and 5-FU.

Lipids are optimized, but CAD persists. Is inflammation the real enemy?
Inflammation's role in coronary artery disease is clearer in 2026, with low-dose colchicine showing efficacy and social isolation emerging as a risk factor.

Vapes, Snus, and Nicotine: What Cardiologists Must Know About ESC's New Stance
The European Society of Cardiology issued a policy statement on nicotine products, clarifying cardiovascular risks and informing clinical practice.

More oxygen, less heart recovery in VA-ECMO? The paradox
Maintaining high oxygen levels in VA-ECMO patients may impair myocardial recovery, challenging current practices that often target supranormal arterial oxygen partial pressures.

Non-drug strategies for post-op delirium after cardiac surgery
Multicomponent non-pharmacological interventions reduce post-operative delirium incidence and severity in cardiac surgery patients.

AFib ablation: Is your current timing maximizing patient benefit?
A post-hoc analysis of the CABANA trial suggests earlier catheter ablation for AFib improves outcomes, particularly for patients with paroxysmal AF.

Beyond clinical signs: VExUS/LUS reveals heart failure's true volume
Early changes in VExUS score and lung ultrasound (LUS) correlate with outcomes in acute decompensated heart failure, offering a non-invasive prognostic indicator.

Dilated cardiomyopathy: Is your patient's genotype dictating their risk?
Genetic variations influence dilated cardiomyopathy outcomes, with specific mutations correlating to differing risks of heart failure events and mortality.

Atrial Fibrillation in LVNC: Is it a distinct arrhythmia or a marker of disease?
Atrial fibrillation in left ventricular non-compaction (LVNC) presents unique challenges, with new insights clarifying its prevalence and clinical implications.

LVAD RVF: The real reason current risk scores miss the mark
Existing risk scores for right ventricular failure after LVAD implantation show modest predictive value, with EUROMACS performing best but needing refinement.

Why your annual flu jab recommendation is doing double duty for AFib
Influenza vaccination correlates with a reduced risk of new-onset atrial fibrillation, suggesting a broader cardiovascular protective effect beyond respiratory illness.

Aficamten: A New Path for Non-Obstructive Hypertrophic Cardiomyopathy?
Aficamten shows promise for non-obstructive hypertrophic cardiomyopathy, a condition with limited treatment options. The drug targets cardiac myosin, reducing contractility and improving symptoms.

Ruling Out Heart Attacks Faster: The PRESC1SE-MI Study's ED Impact
The PRESC1SE-MI study demonstrated a novel algorithm using high-sensitivity troponin I can safely rule out myocardial infarction in the emergency department within one hour.

Do Statins Still Benefit Patients Over 70 Without Prior CVD?
The STAREE trial investigated statin use for primary prevention in individuals over 70, challenging long-held assumptions about cardiovascular benefit in this age group.

Factor XIa Inhibitors After Heart Attack: A New Antithrombotic Path?
Factor XIa inhibitors offer a novel antithrombotic strategy after myocardial infarction, aiming for reduced bleeding risk compared to current agents.

Why Transthyretin Amyloid Cardiomyopathy Remains Underdiagnosed
Transthyretin amyloid cardiomyopathy (ATTR-CM) often presents with non-specific symptoms, leading to significant diagnostic delays and missed opportunities for early intervention.

GLP-1 Agonists: Do They Prevent Heart Disease in the General Population?
GLP-1 receptor agonists reduce cardiovascular risk in obese individuals with established CVD, but their benefit in primary prevention remains unclear.

Faster Heart Attack Rule-Out: Can PRESC1SE-MI Deliver on ED Efficiency?
A new strategy for ruling out myocardial infarction in emergency departments, using high-sensitivity troponin and clinical risk scores, demonstrated high safety and reduced length of stay.

Do Statins Prevent Dementia in Healthy Older Adults? STAREE Trial Weighs In
The STAREE trial investigated statin use in healthy adults over 70, finding no reduction in dementia incidence but a modest cardiovascular benefit.

Eplontersen: Can a new RNAi therapy change ATTR-CM outcomes?
Eplontersen significantly reduced transthyretin protein levels and improved clinical endpoints in ATTR amyloid cardiomyopathy.

Aficamten targets non-obstructive HCM, a disease with no approved drug
Aficamten shows promise for non-obstructive hypertrophic cardiomyopathy, a condition lacking specific approved therapies.

Can Factor XIa Inhibitors Reduce Post-MI Bleeding Without Compromising Efficacy?
Factor XIa inhibitors aim to reduce thrombotic events in acute coronary syndrome patients while minimizing bleeding risk, a critical balance in post-MI care.

ESC Congress 2026: The 59 Pivotal Trials You Need to Know
Fifty-nine pivotal trials will present at ESC Congress 2026, covering major cardiovascular disease areas from heart failure to arrhythmia.

EHR data identifies liver transplant patients at high risk of early graft loss
An EHR-based marker accurately identifies liver transplant recipients at elevated risk of early graft failure and mortality, offering a tool for improved post-transplant management.
Are SGLT2 and GLP-1 the missing link in cardiorenal-metabolic care?
SGLT2 inhibitors and GLP-1 receptor agonists are transforming care for cardiorenal-metabolic diseases, moving beyond glucose control to broad organ protection.

Living donation: What's truly behind rapid APOL1 kidney decline?
Individuals with two APOL1 risk alleles experience a greater decline in kidney function after living donation, raising concerns for donor selection.

C3G: Pegcetacoplan or iptacopan? Why indirect data complicates your choice
Indirect comparisons suggest pegcetacoplan may offer superior efficacy in C3 glomerulopathy, but head-to-head trials are absent.

Pediatric EoE: Why some symptoms persist despite standard care
Children with eosinophilic esophagitis and hypermobility exhibit worse autonomic symptoms, including orthostatic intolerance and gastrointestinal dysmotility.

IgAV-N in children: High risk, low evidence. A path for better trials
IgA vasculitis nephritis in children progresses to kidney failure, but clinical studies are few. An international workshop identified barriers to high-quality evidence.

Why children with IgA vasculitis nephritis still lack targeted therapies
New KDIGO guidelines highlight a persistent gap in clinical trial data for children with IgA vasculitis nephritis, leaving them without specific treatment recommendations.

IgA Nephritis: Known threat, unknown plan for older transplants
Current research on IgA nephritis post-transplant largely excludes older patients, leaving a significant gap in evidence for managing this complex population.

Why nephrology inpatients are sicker, more complex, and harder to manage
Nephrology inpatients present with increasing comorbidity burden and acuity, driven by an aging population and advanced chronic kidney disease.

Is Fabhalta the long-term IgAN solution we've needed?
Fabhalta (iptacopan) received full FDA approval for IgA nephropathy, converting its accelerated approval based on proteinuria reduction.

Donor T-cells prevent CMV complications in blood cancer patients
The FDA approved a new donor T-cell therapy to prevent cytomegalovirus (CMV) infection and disease in high-risk blood cancer patients post-transplant.

Naloxone moves OTC: Will broader access curb opioid overdose deaths?
The FDA has approved an over-the-counter naloxone nasal spray, aiming to increase accessibility and reduce opioid overdose fatalities.

The real reason foreign tobacco products avoided US standards
The FDA proposes a new rule to ensure foreign tobacco product manufacturers comply with US regulations, aiming to protect public health by closing a regulatory loophole.

Influenza treatment: The single-dose option challenges multi-day adherence
The FDA approved the first single-dose generic influenza treatment, offering a new option for patients seeking convenient antiviral therapy.

Oral PCSK9 Inhibitor Approved: A New Era for LDL Cholesterol Management?
The FDA approved laroprovstat, the first oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with high cholesterol, offering a non-injectable option.

Screwworm EUA: How targeting larval development changes prevention
The FDA issued Emergency Use Authorization for a drug to prevent New World screwworm infestations in horses, offering a critical short-term solution.

The hidden data gap behind recurring drug shortages
The FDA proposes modernizing drug manufacturing registration, requiring facility-specific data and unique facility identifiers to enhance supply chain oversight.

Tzield expands its reach: A new option for recently diagnosed pediatric type 1 diabetes
The FDA approved Tzield (teplizumab) for pediatric patients with recently diagnosed Stage 3 type 1 diabetes, marking an expansion of its indication.

Treating screwworm: Why an OTC generic is now the frontline
The FDA issued an Emergency Use Authorization for a generic over-the-counter drug to treat New World screwworm infestations in companion animals.

Cell and gene therapy approvals speed up. What does it mean for your practice?
The FDA issued new draft guidance to accelerate cell and gene therapy development, aiming to clarify regulatory pathways and expedite patient access.

How non-animal models are redefining oncology drug safety
The FDA issued draft guidance to reduce animal testing for oncology drugs, allowing sponsors to use non-animal methods for certain safety and efficacy assessments.

Chronic Hepatitis Delta Virus: Why direct viral targeting matters now
The FDA has approved the first treatment for chronic hepatitis delta virus (HDV) infection, addressing a severe form of viral hepatitis with high mortality.

Your patient's child could be exposed to hidden tobacco dangers
The FDA issued warnings to retailers distributing illegal tobacco products designed to resemble common items, posing a significant public health risk, particularly to children.

BHT, ADA, and food chemicals: When 'safe' isn't forever
The FDA finalized its post-market assessment program for food chemicals, immediately launching reassessments of butylated hydroxytoluene (BHT) and adenosine deaminase (ADA). This move signals a shift towards proactive safety evaluations for substances already in the food supply.

Is the future of drug discovery already on your pharmacy shelf?
The FDA is streamlining drug repurposing, leveraging existing data to identify new indications and expedite therapies for unmet medical needs.

A bureaucratic voucher is now driving rare disease drug development
The FDA granted its seventh priority review voucher, incentivizing drug development for rare pediatric and tropical diseases.

Drug approvals: FDA's pivot to speed and supply. Can both truly thrive?
The FDA selected seven participants for its PreCheck pilot program, aiming to streamline drug manufacturing inspections and enhance supply chain resilience.

Australia's smoking rate drops to 5.6% daily, defying 'comeback' claims
Just 5.6% of Australians now smoke daily, a significant decline that contradicts recent narratives about a resurgence in smoking.

How microplastics in blood may trigger acute myocardial infarction.
Patients experiencing acute myocardial infarction show higher levels of micro and nanoplastics in their blood, suggesting a potential link to cardiovascular events.

The antibiotic paradox: More drugs won't solve resistance
Antibiotic resistance is a growing global health crisis, but a multi-pronged approach beyond novel compounds offers tangible solutions for clinicians.

Melatonin: Adjunctive, non-opioid for chronic musculoskeletal pain?
Melatonin, a hormone known for sleep regulation, may reduce chronic musculoskeletal pain, offering a potential non-opioid treatment option.

Bilingualism and dementia: Is it delay, or true prevention?
Speaking multiple languages may not directly lower dementia risk, but it could delay symptom onset by enhancing cognitive reserve, a mechanism distinct from disease prevention.

Disabled astronauts: Why some disabilities may be strengths in space
Individuals with certain disabilities may possess inherent physiological and psychological adaptations that make them uniquely suited for long-duration space missions, challenging traditional astronaut selection criteria.

Walking football: A prescription for sedentary older adults?
Walking football provides a unique blend of physical activity and social engagement for older adults, challenging traditional views of ageing.

Newborn screening: Why communicating complex genetics just got harder
Expanding newborn screening panels requires precise communication with parents to manage expectations and ensure informed consent for complex genetic conditions.

Meningitis B: Why campus life shifts vaccine guidance for your patients
The MenB vaccine is now available for university students in Europe, targeting a population at increased risk for invasive meningococcal disease.

Heat-related mortality: When housing becomes a clinical risk
Heat-related mortality disproportionately affects vulnerable populations in Europe, with substandard housing and urban heat islands exacerbating the public health crisis.

Metabolic Syndrome: Is it accelerating your patients' brain aging?
Metabolic syndrome, affecting one in four adults, significantly accelerates brain aging and increases the risk of cognitive decline, impacting neurovascular health.

Interceptions aren't just muscle: fatigue erodes decision speed
Player fatigue substantially diminishes the rate of successful ball interceptions in World Cup matches, impacting defensive efficacy and game outcomes.

Jude Bellingham's Prominent Leg Veins: A Physiologic Response to Elite Athleticism
Jude Bellingham's visible leg veins are a normal physiological adaptation to intense endurance training, not a sign of pathology. This vascular prominence reflects increased blood flow and efficient oxygen delivery.

Beetroot Juice Fails to Boost Sports Performance in Latest Study
Beetroot juice, often touted for athletic benefits, did not improve sports performance in a recent investigation, challenging popular claims.

Botticelli's Muse: Has a 550-Year-Old Medical Case Been Solved?
New analysis suggests pulmonary tuberculosis, complicated by a rare genetic disorder, may have killed Simonetta Vespucci, Botticelli's muse, 550 years ago.

Heatwaves hit hard, but prescribing 'cool' isn't enough
Heatwaves disproportionately affect vulnerable populations in the UK, exacerbating existing health disparities. Targeted interventions are essential to mitigate morbidity and mortality.

Black Death Survivors' Genetic Legacy Offers Clues for COVID-19 Resilience
Genetic analysis of medieval plague survivors reveals specific immune system adaptations that may offer insights into modern infectious disease resilience, including COVID-19.

Long COVID: Objective Biomarkers Challenge Psychosomatic Narrative
Emerging objective biomarkers for Long COVID, including immune dysregulation and microclots, directly contradict the long-standing psychosomatic explanation for patient symptoms.

Weight-Loss Jabs May Create a New Kind of Yo-Yo Dieting
GLP-1 receptor agonists, while effective for weight reduction, present a significant risk of weight regain upon cessation, challenging long-term management strategies.

World Cup Football Offers Lessons for Managing Extreme Fatigue
Elite football provides a unique model for understanding and mitigating fatigue in high-pressure, extreme conditions, with implications for clinical practice.

Football Headers Linked to Cognitive Decline, Neurodegeneration
Repeated head impacts from football headers correlate with increased risk of cognitive impairment and neurodegenerative disease, particularly in former professional players.

Tired Yet Wired: Blame Your Stone-Age Brain for Modern Sleep Woes
Chronic stress keeps the ancient fight-or-flight response active, preventing restorative sleep despite physical exhaustion. This evolutionary mismatch drives modern insomnia.

Keeping Medicines Safe in Heat: Essential Advice for GPs
High temperatures compromise drug stability and efficacy. GPs must advise patients on proper medicine storage to prevent treatment failures and adverse events.

Forget sterile tumors: Cancers house unique microbiomes
A comprehensive analysis of over 17,000 tumor samples confirms distinct microbial signatures across 35 cancer types, influencing prognosis and treatment response.

Sitting for Long Stretches Linked to Higher Cancer Mortality Risk
Extended sedentary time increases the risk of death from cancer, particularly for specific cancer types, independent of physical activity levels.

New Virus Catalogue Identifies Top Pathogen Threats to Human Health
A comprehensive virus catalogue identifies pathogens posing the greatest threat to human health, prioritising those with pandemic potential.

Pain's Enduring Role in Functional Decline for Cancer Survivors
Pain significantly contributes to functional decline in cancer survivors, impacting independence and mobility, according to recent research.

Childhood Maltreatment Memories: Trustworthy, Not Fabricated
New research challenges the long-held notion that memories of childhood maltreatment are inherently unreliable, affirming their consistency and clinical utility.

Menthol vapes: A cool sensation, a cardiac disruption?
Vaping liquids containing cooling agents, such as menthol, may disrupt cardiac electrical activity and increase the risk of arrhythmias, according to preclinical research.

Your patients face higher maternal risks from immigration policy
US immigration policies create significant barriers to prenatal care and parenting choices, leading to adverse health outcomes for pregnant individuals and their children.

Nursing Students Could Bolster Public Health at Major Sporting Events
Major sporting events offer a unique opportunity for nursing students to gain practical public health experience and support community well-being.

NZ Health: How can a modern system consistently underperform?
New Zealand's current health expenditure is insufficient to meet existing demands, with projections indicating a substantial funding gap for future needs.

Cancer survival improves. Why are rural outcomes still worsening?
Patients in rural areas face significant disparities in cancer treatment access and prevention, leading to worse outcomes compared to their urban counterparts.

Sodium Fluoroacetate Offers Hope Against Australia's Mouse Plagues
Australian farmers may soon find relief from devastating mouse plagues with sodium fluoroacetate, a highly effective rodenticide showing promise in controlling infestations.

South African Scientists Decipher Cancer's Survival Strategy
Researchers in South Africa have uncovered a key mechanism cancer cells exploit to evade immune detection, offering new targets for therapeutic intervention.

Vaccine Hesitancy: More Than Just Misinformation
Understanding why some individuals decline vaccination requires examining complex factors beyond simple misinformation, including trust, access, and personal experience.

HPV Vaccine Efficacy Hinges on Sustained Trust and Uptake
The HPV vaccine effectively prevents cervical cancer and other HPV-related diseases, but its long-term impact relies on consistent public health messaging and high vaccination rates.

Vaccine Hesitancy: South Africa, Brazil Reveal Complex Drivers Beyond Simple Factors
Vaccine hesitancy in South Africa and Brazil stems from diverse, context-specific factors, challenging single-cause explanations and demanding tailored public health approaches.

NZ Winter: Who Needs COVID, Flu, RSV Vaccination?
New Zealand faces a triple threat of respiratory viruses this winter. Understanding current vaccination recommendations for COVID-19, influenza, and RSV is critical for clinicians.

The counterintuitive cost of quarantine: Lasting mental health scars
Historical quarantines, from plague to smallpox, reveal profound and lasting psychological and socioeconomic impacts on individuals and communities.

Europe's Record Heatwave: A Confluence of Atmospheric Dynamics and Human Vulnerability
Europe faces a severe heatwave driven by high-pressure systems and climate change, exacerbating health risks for vulnerable populations.

Australia's Lung Cancer Screening: A Year In, Can Health System Deliver?
Australia's national lung cancer screening program completed its first year, raising critical questions about the health system's capacity to manage the influx of diagnoses and follow-up care.

Ivermectin Fails to Show Cancer Efficacy, Despite Influencer Claims
Ivermectin lacks clinical evidence for cancer treatment, yet online influencers promote it as a miracle drug, diverging sharply from scientific consensus.

The hidden infrastructure flaws that cloud CDC disease tracking
Gaps in CDC's public health data hinder effective disease tracking and prevention efforts, creating dangerous blind spots in areas from maternal health to influenza rates.

Childhood vaccinations: Pharmacists fill a gap, but what’s the cost for GPs?
New policy changes will allow more pharmacists to administer childhood vaccinations to children under 5, expanding access but raising questions for primary care.

Toxic Algae Behind South Australia Bloom Among Deadliest Ever Tested
A microalgae species responsible for harmful blooms in South Australia produces toxins among the most potent ever recorded, posing significant public health risks.

Canada's Vaccine Infrastructure Protected FIFA World Cup Attendees
Canada's established vaccine infrastructure, honed by previous mass vaccination campaigns, proved critical in preventing infectious disease outbreaks during the FIFA World Cup.

NZ Healthcare Corporatisation Threatens Access, Quality
The increasing corporatisation of New Zealand's healthcare system poses significant risks to patient access and service quality, demanding close scrutiny from clinicians.

LLMs Prioritize Western Morals, Overlooking Diverse Cultural Values
Large language models frequently embed Western moral frameworks, potentially marginalizing ethical considerations from other global cultures in their outputs.

First Nations patients report racism, but cultural safety training improves care
First Nations people frequently experience racism in healthcare settings, but culturally safe care, delivered by trained providers, significantly improves patient experience and health outcomes.

CDC Cuts Undermine US Public Health Capacity, Threatening Preparedness
Decades of underfunding and budget cuts have eroded the CDC's ability to protect Americans, leaving the nation vulnerable to emerging health threats and outbreaks.

Brief CBT Workshop Reduces Anxiety, Boosts Grit in Primary Students
A brief cognitive behavioral therapy workshop significantly reduced anxiety and improved active coping strategies and grit among primary school students in Malaysia.

Peptide Therapies: Decoding Evidence from Topicals to Longevity
Peptide therapies show varied efficacy across indications, from established dermatological uses to investigational longevity applications. Clinicians must scrutinise the evidence for each specific peptide.

26 States Sue to Block Medicaid Work Requirements, Citing Access Concerns
A coalition of 26 states filed suit to prevent the implementation of Medicaid work requirements, arguing the policy jeopardizes healthcare access for vulnerable populations.

Obamacare Enrollment Shrinks in Many States, Federal Data Shows
New federal data reveals a significant decrease in Obamacare enrollment across numerous states over the past year, impacting access to health coverage.

ACA Insurers Seek Higher Premiums Amid Enrollment Decline
Affordable Care Act insurers are requesting substantial premium increases for 2025, citing a decline in enrollment and rising healthcare costs.

Leapfrog Group's Legal Defeat Underscores Hospital Quality Rating Challenges
A recent court ruling against the Leapfrog Group highlights the significant hurdles in accurately and fairly rating hospital quality, raising questions about current methodologies.

Dana-Farber CEO Details Split from Mass General Brigham, New Hospital Plans
Dana-Farber Cancer Institute CEO Laurie Glimcher outlined plans for an independent future, including a new cancer hospital, following its separation from Mass General Brigham.

Judge Temporarily Blocks Subpoenas in NY Transgender Care Probe
A New York judge temporarily blocked subpoenas seeking patient records in a criminal probe of transgender care at two hospitals, citing patient privacy concerns.

NIH diversity programs doubled PhD odds for undergraduates, 20-year study finds
NIH-funded diversity programs significantly increased the likelihood of undergraduates earning a PhD, doubling their odds over two decades.

Next-Gen CRISPR Improves Embryo Editing Accuracy, Stoking Ethical Debate
Advanced CRISPR tools enhance precision in human embryo gene editing, reducing off-target effects but intensifying ethical concerns over germline modification.

Synthetic Cell Raises Fundamental Questions About Life's Definition
Researchers have created a synthetic cell capable of self-replication, challenging established biological definitions of life and raising ethical considerations.

FDA Clears LLM for Triage: Interface or Decision-Maker?
The FDA cleared an LLM for acute pancreatitis triage, raising questions about its role as an interface versus a primary decision-maker in clinical settings.

AI Regulator: Biopharma Misinterprets FDA Guidance on Machine Learning
A former FDA AI regulator states biopharma companies are misreading agency guidance, potentially hindering AI adoption in drug development and clinical trials.

Online GLP-1 Prescriptions Often Lack Clinical Oversight
Rapid online GLP-1 prescriptions frequently bypass essential clinical assessments, raising concerns about patient safety and appropriate use.

Congressman Kean Jr. Reveals Depression Diagnosis After Absence
Representative Tom Kean Jr. disclosed a depression diagnosis following a four-month absence from Congress, highlighting the prevalence of mental health conditions.

GOP Lawmakers Push FDA on Clinical Trial Diversity
Republican lawmakers are pressing the FDA to enforce greater diversity in clinical trials, citing concerns over health equity and drug efficacy across varied populations.

Trump Administration Seeks Durable Science Policy Changes After Court Setbacks
The Trump administration is pursuing more lasting alterations to federal science policy, shifting focus to regulatory changes after previous court challenges.

Presidential Fitness Test: A Step, Not a Solution for Public Health
The new presidential fitness test offers a positive step toward promoting physical activity but falls short as a comprehensive public health strategy, experts contend.

CGMs in Toddlers: Balancing Glycemic Control with Developmental Risks
Continuous glucose monitors offer tighter glycemic control in toddlers with type 1 diabetes, but concerns persist regarding skin integrity, device adherence, and neurocognitive development.

Lung Transplants Extend Survival for Select Stage 4 Cancer Patients
Lung transplantation significantly extended survival for a highly selected cohort of stage 4 lung cancer patients whose disease had not spread beyond the chest.

Novartis Acquires Mariana Oncology, Republicans Back Trial Diversity
Novartis expands its radioligand therapy pipeline with Mariana Oncology acquisition, while Republicans advocate for clinical trial diversity.

Vertex Acquires Alpine Immune Sciences for $4.9 Billion, Expanding Autoimmune Pipeline
Vertex Pharmaceuticals will acquire Alpine Immune Sciences for $4.9 billion, gaining povetacicept, a Phase II-ready treatment for autoimmune diseases.

Vera Kidney Drug Wins Approval, Enhertu UK Deal Reached
Vera Therapeutics' atacicept secured FDA approval for IgA nephropathy, while a UK pricing deal will expand Enhertu access for breast cancer.

Bluebird Bio's Zynteglo, Skysona Face Market Realities Post-Buyout
A year after its distressed buyout, Bluebird Bio navigates commercialisation challenges for its gene therapies Zynteglo and Skysona, despite clinical efficacy.

Vertex Acquires Crinetics for $10B, Bolstering Endocrine Pipeline
Vertex Pharmaceuticals acquired Crinetics Pharmaceuticals for $10 billion, securing a late-stage endocrine pipeline, including an oral somatostatin receptor agonist.

Prime Medicine Wins Gene-Editing Dispute Against Beam Therapeutics
Prime Medicine has secured a victory in its intellectual property dispute with Beam Therapeutics over foundational gene-editing technology.

MAHA Monday: The Rush to Publish and Its Clinical Fallout
The annual 'MAHA Monday' sees a deluge of abstracts for the American Society of Hematology meeting, creating a bottleneck for peer review and raising questions about the quality of early data dissemination.

Obesity as Disease: Who Benefits from the Redefinition?
Classifying obesity as a disease shifts focus from lifestyle to medical intervention, benefiting pharmaceutical companies and specific patient subgroups.

Cannabis Use in Older Adults: Doctors Can Guide Safe Practices
Older adults increasingly use cannabis for various conditions. Clinicians must understand its pharmacology and potential interactions to guide safe use.

AstraZeneca, Ionis Heart Disease Drug Fails Major Trial
AstraZeneca and Ionis's investigational heart disease drug did not meet its primary endpoint in a pivotal trial, marking a significant setback.

Drug Approval Delays: 931 Days and Counting for European Patients
European patients wait an average of 931 days longer than US patients for access to new medicines, a systemic delay impacting clinical outcomes and public health.

Whistleblower Exposes Health Insurer's Denials, Challenges Political Machine
A former medical director exposed a major health insurer's systematic denial of claims, sparking a legal and political battle. Her efforts highlight the ongoing struggle for patient advocacy.

US Small Businesses Abandon Health Insurance Amid Rising Costs
America's small businesses are increasingly dropping employer-sponsored health insurance, citing unsustainable premium increases and administrative burdens.

Rare Disease Patients Face Hurdles Beyond Diagnosis, Treatment
The quest to save Grace, a patient with a rare genetic disorder, highlights systemic barriers in clinical trial access and regulatory pathways for orphan diseases.

Federal Health Nominee's Vaccine Skepticism Raises Concerns
A nominee for a key federal health role has a documented history of questioning established vaccine efficacy and safety, prompting scrutiny from medical organizations.
Roche Halts Huntington's Gene-Silencing Programs
Roche has ended its gene-silencing programs for Huntington's disease, including tominersen, after clinical trials failed to show benefit or raised safety concerns.

Bryan Johnson's Chronic Disease: A Diagnostic Labyrinth
Bryan Johnson's chronic disease, a notoriously difficult condition to diagnose, highlights the complexities of identifying rare and multifactorial illnesses.

ARPA-H Funds $160M Gene Editing Effort for Custom Therapies
ARPA-H launched a $160 million initiative to develop custom gene editing drugs, aiming to create rapid, on-demand therapies for a range of diseases.

Diarrhea Parasite Outbreak Exceeds 1,000 Cases Across Europe
A widespread outbreak of a diarrhea-causing parasite has surpassed 1,000 confirmed cases, prompting public health warnings across several European nations.

Whistleblower Exposes Health Insurer Practices, FDA Commissioner Candidates
A former health insurance executive has detailed alleged systemic denial of care and influence peddling, raising questions for FDA commissioner nominees.

Boston Doctor's 'Loud and Unafraid' Voice in Trump Era Resonates
A Boston physician built a significant following by speaking out on public health issues during the Trump administration, blending medical expertise with direct political commentary.

Buprenorphine Training Lags in Pain Fellowships Amid Opioid Crisis
Despite the opioid crisis, buprenorphine education remains underemphasized in pain medicine fellowships, limiting access to a critical treatment for OUD and chronic pain.

New York's Old Boys' Clubs Offer Mental Health Buffer
Exclusive social clubs in New York City provide a structured environment that may mitigate mental health decline among members, fostering resilience through consistent social engagement and shared purpose.

Ebola in Congo: Global Response Capacity Disappears Amidst Conflict
The ongoing Ebola outbreak in the Democratic Republic of Congo highlights critical failures in global health response, exacerbated by conflict and resource diversion.

Nurses' Mental Health: Anonymous Study Seeks Experiences
An anonymous study is collecting data on nurses' mental health experiences, aiming to quantify the prevalence of stress, burnout, and psychological distress within the profession.

FDA Employees Learned Boss Was Gone Via Email, Not In-Person
FDA employees learned of their commissioner's departure through an agency-wide email, not a direct announcement, revealing a disconnect in internal communication.

Ebola Outbreaks Demand Swift, Coordinated Public Health Response
Former CDC Chief Tom Frieden emphasizes the critical need for rapid, coordinated public health interventions to contain Ebola outbreaks, highlighting lessons from past epidemics.

COVID Vaccine Efficacy Wanes, Boosters Essential for Sustained Protection
Initial COVID-19 vaccine efficacy significantly declines over several months, necessitating booster doses to maintain robust protection against infection and severe disease.

Hantavirus: Essential Information for European Clinicians
Hantavirus presents with varied clinical syndromes, including HFRS and HCPS, requiring prompt recognition for effective management.

Common Drugs Basically Flunk for Long COVID Fatigue
Established therapies, including stimulants and antidepressants, show minimal to no benefit for the debilitating fatigue associated with long COVID.

Oral Rehydration Solutions: The Unsung Hero of Concert Medicine
Oral rehydration solutions (ORS) are the essential, often overlooked, treatment for acute gastroenteritis and dehydration, proving critical in high-density public health scenarios.

Knicks' New Team Doctor Brings Orthopedic Expertise to NBA Sidelines
The New York Knicks appointed Dr. Andrew Pearle as their new team doctor, bringing extensive orthopedic and sports medicine experience to the franchise.

Liver Transplant Studies Retracted Over Organ Harvesting Concerns
Multiple liver transplant studies have been retracted from major medical journals due to concerns over the ethical sourcing of donor organs, raising serious questions about research integrity.

HHS Moves to Create List of COVID Vaccine Injuries, Citing Unmet Need
The HHS is establishing a new system to track COVID-19 vaccine injuries, acknowledging a gap in current surveillance and patient support mechanisms.

Men Face Later Cancer Diagnoses Across 20 Types
Men are more likely to receive a later-stage cancer diagnosis across 20 different cancer types, leading to worse prognoses and treatment outcomes.

Targeted Therapy Reverses Weight Gain From Rare Cause of Obesity
A targeted therapy effectively reversed weight gain in patients with a rare genetic form of obesity, demonstrating significant reductions in body weight.

600 Dead in Outbreak; Obamacare Now Trumpcare? Rare Cancer Cluster in Kids
A severe outbreak has claimed 600 lives, while policy shifts threaten healthcare access. A rare pediatric cancer cluster raises urgent public health concerns.

Lawmakers Push CDC to Track Vitamin K Refusals Amid Bleeding Risk
US lawmakers demand the CDC track parental refusals of the vitamin K shot for newborns, citing a ProPublica report on rising rates of life-threatening bleeding.

ADCs Advance First-Line TNBC Treatment, Improving PFS
Antibody-drug conjugates are improving progression-free survival in first-line triple-negative breast cancer, offering new options for patients.

CDC Reverses Chickenpox Vaccine Guidance, Impacting Pediatricians and Public Health
The CDC has reversed its stance on chickenpox vaccine recommendations, shifting from universal childhood vaccination to a more targeted approach for specific risk groups.

Viral NeeDoh Trend Leads to Scalding Injuries, Doctors Warn
Doctors report a rise in scalding injuries among children due to a viral trend involving heating NeeDoh stress balls, prompting urgent warnings for parents.

FDA Expands Chemo-Free Bladder Cancer Combo for Curative Setting
The FDA broadened approval for a chemotherapy-free combination in bladder cancer, offering a new option for patients ineligible for cisplatin.

ED Visits Precede Cancer Diagnoses; Radiation Access Shrinks
Emergency department visits often precede a cancer diagnosis, indicating missed opportunities for earlier detection. Meanwhile, radiation oncology access is declining.

AI-Triggered Nephrology Consult Fails to Prevent AKI in Trial
An AI-driven alert system for acute kidney injury risk did not reduce AKI incidence or severity when triggering nephrology consults in hospitalised patients.

Lawmakers Call for Oversight on Physician-Assisted Suicide in Hospice
Lawmakers express concerns over the increasing availability of physician-assisted suicide for hospice patients, citing potential for coercion and inadequate safeguards.

Diarrhea Surges in Quake-Hit Venezuela Amid Humanitarian Crisis
A significant increase in diarrheal diseases is impacting Venezuela's earthquake-affected regions, exacerbating an already dire humanitarian situation.

Cyclosporiasis Outbreak: Stay Safe, Enjoy Summer Produce
Cyclosporiasis outbreaks linked to contaminated produce are a recurring summer concern. Proper washing and handling of fruits and vegetables are essential to prevent infection.

More Than Half of CDC Centers Lack Permanent Leadership
Over 50% of the Centers for Disease Control and Prevention's 13 centers, institutes, and offices operate without permanent directors, raising concerns about long-term strategy and response capabilities.

Mosquito-borne diseases surge, challenging European public health
Climate change drives a rapid expansion of mosquito vectors across Europe, increasing the risk of endemic and imported diseases like dengue and West Nile virus. Public health systems face unprecedented challenges.

Private Equity's AI Push: Old Questions for Healthcare
Private equity firms are investing heavily in AI for healthcare, raising concerns about data privacy, clinical efficacy, and the potential for profit-driven care models.

Earthquake Aftermath: Clinical Priorities for GPs and Specialists
Immediate clinical priorities following an earthquake include crush injury management, infection prevention, and mental health support for survivors.

PTSD Not a Shield for Sexual Misconduct, Clinicians Affirm
Post-traumatic stress disorder does not mitigate accountability for sexual misconduct, a consensus among mental health professionals confirms, rejecting the notion of PTSD as a blanket excuse.

GLP-1 Agonists, Newer Diabetes Drugs, Linked to Autoimmunity Risk
Newer diabetes treatments, including GLP-1 agonists, carry an elevated risk for autoimmune conditions, requiring careful patient monitoring.

Adderall Execs Jailed; FDA Warns on Ketamine; Wellness Cult Psychosis
Executives received prison sentences for an Adderall distribution scheme. The FDA issued a warning regarding compounded ketamine. Wellness cults are linked to psychosis cases.

Vitamin C's cognitive promise clashes with new clinical data
Vitamin C supplementation does not improve cognitive function in healthy adults. Advanced MRI reveals previously undetectable MS lesions, while new criteria define profound autism.

Eye Specialists Question Value of Pricey Cataract Lenses
European ophthalmologists are raising concerns about the increasing use and cost of premium intraocular lenses in cataract surgery, citing limited evidence of superior patient outcomes.

Katie Couric's Transient Global Amnesia: A 'Big, Black Hole' Event
Katie Couric recently described an episode of transient global amnesia, a sudden, temporary loss of memory that can be alarming but is typically benign.

Haaland's 6,000-Calorie Diet: Performance Fuel or Health Risk?
Erling Haaland's reported 6,000-calorie daily diet, while fueling elite athletic performance, presents significant long-term health considerations for the general population.

Acute Flaccid Myelitis Cases Stable Despite Enterovirus Rise
Despite an increase in enterovirus infections, acute flaccid myelitis incidence has not risen, challenging assumptions about disease correlation.

Dermatomyositis Guidelines Identify Cancer Risk
New guidelines provide a structured approach for identifying dermatomyositis patients at high risk for cancer, streamlining screening protocols for European clinicians.

MAHA environmental data: The hidden reason clinicians get nothing new
The Environmental Protection Agency promised a robust agenda to address microangiopathic hemolytic anemia (MAHA) but has delivered little, drawing criticism from advocacy groups.

Doctor Misconduct Alerts Face Months-Long Delays in State Law
State laws mandate public alerts on doctor misconduct allegations, but the process can take months, leaving patients unaware of potential risks.

Disinformation Resolutions Miss Core Clinical Realities
Efforts to combat medical disinformation often overlook the practical constraints and cognitive biases inherent in clinical practice, rendering them less effective.

Respiratory Virus Testing in Nursing Homes: A Deep Dive
Proactive testing for respiratory viruses in nursing homes can mitigate outbreaks, but implementation challenges persist in European facilities.

GLP-1 Drugs: Semaglutide, Tirzepatide Show Varying Benefits, Harms in T2D
A living systematic review compared GLP-1 receptor agonists for type 2 diabetes, finding differences in cardiovascular outcomes, weight loss, and adverse events.

Surgical Start Time Does Not Impact Cataract Complication Rates
New research indicates that the time of day cataract surgery begins has no bearing on postoperative complication rates, challenging long-held assumptions.

Presbyopia Treatment Needs Personalisation, Not One-Size-Fits-All
Patient-specific factors dictate satisfaction with presbyopia-correcting intraocular lenses, with preoperative simulation tools emerging to tailor treatment.

AXS-05 Reduces Agitation in Alzheimer's Disease Patients
AXS-05 significantly reduced agitation in patients with Alzheimer's disease, demonstrating efficacy and a favorable safety profile in the ACCORD-2 trial.

Dementia care: How much of the family's financial burden do you see?
Dementia significantly increases medical expenditures for patients and reduces income for their caregivers, placing substantial financial strain on families.

Surgical Fixation May Improve QoL for Pickleball Achilles Ruptures
Surgical repair of Achilles tendon ruptures sustained during pickleball may offer superior quality of life outcomes compared to non-operative management.

Vapes, Nicotine Pouches Linked to Achilles Tendon Complications
Nicotine product use, including vapes and pouches, significantly increases the risk of complications and re-rupture after Achilles tendon repair.

Plastics in Personal Care Products: Evidence for Harm Mounts
Microplastics and nanoplastics in personal care products pose significant health risks, acting as endocrine disruptors and contributing to systemic inflammation.

Satellite Imaging, AI Enhance Environmental Perception in Cardiometabolic Disease
Advanced satellite imaging and artificial intelligence improve the assessment of environmental factors impacting cardiometabolic disease, offering new avenues for risk stratification and intervention.

Extreme Heat Demands Environmental Integration in Cancer Care
Integrating environmental factors, particularly extreme heat, into cancer care is no longer optional; it is a clinical necessity for patient safety and treatment efficacy.

MDD Care Gaps Persist, Limiting Access to Effective Therapies
Major depressive disorder treatment faces significant access barriers, leaving many patients without adequate care despite available therapies.

FDA Approves Xocova for Post-Exposure COVID-19 Prevention
The FDA granted emergency use authorization for Xocova (ensitrelvir) to prevent COVID-19 after exposure, offering a new tool against SARS-CoV-2.

COVID-19, Flu Vaccine Coadministration May Lower MACE Risk in Older Adults
Coadministration of the 2024-2025 COVID-19 vaccine with an influenza vaccine reduced major adverse cardiovascular events (MACE) in US veterans.

HHS Terminates COVID-19 Emergency Declarations, Shifting Treatment Landscape
The US Department of Health and Human Services ended its COVID-19 public health emergency declarations, fundamentally altering access to tests, vaccines, and treatments.

Coadministration of COVID-19 and Flu Shots Safe, Efficacious
Simultaneous administration of COVID-19 and influenza vaccines does not compromise safety or immunogenicity, supporting streamlined vaccination efforts.

Retirement: A New Chapter, Not a Clinical Endpoint
Retirement presents a unique opportunity for individuals to redefine their purpose and engage in activities that promote well-being, challenging the perception of it as a decline.

Microbreaks at Work Improve Focus, Reduce Fatigue
Brief, voluntary pauses during work shifts enhance concentration and mitigate fatigue, offering a simple intervention for occupational well-being.

Urcosimod Enters Phase 3 for Neuropathic Corneal Pain
Urcosimod, an investigational therapy, will advance to Phase 3 trials to evaluate its efficacy in treating neuropathic corneal pain, addressing a significant unmet clinical need.

Pembrolizumab Regimens Snag FDA Nod for Muscle-Invasive Bladder Cancer
The FDA approved pembrolizumab for two new indications in muscle-invasive bladder cancer, offering options for patients ineligible for cisplatin or those with residual disease.

Neuroadaptation Key to Presbyopia-Correcting IOL Success, Specialist Says
Neuroadaptation plays a critical role in patient satisfaction and visual outcomes following presbyopia-correcting IOL implantation, a specialist explained. The brain's ability to adjust to new optical input determines functional vision.

Alzheimer's Research Lays Foundation for Precision Medicine
New insights into Alzheimer's disease pathophysiology are establishing a framework for targeted therapies, moving beyond amyloid-centric approaches.

Revision Latarjet Outcomes Match Primary Procedure in Contact Athletes
Revision Latarjet surgery yields comparable positive outcomes to primary Latarjet in contact athletes, offering a reliable solution for recurrent shoulder instability.

How local estrogen manages urogenital atrophy without recurrence risk
Local estrogen therapy, including vaginal estradiol and DHEA, effectively alleviates urogenital atrophy symptoms in breast cancer survivors without increasing recurrence risk.

SGLT2 Inhibitors Reduce Heart Failure Risk in Type 2 Diabetes
SGLT2 inhibitors significantly cut the risk of heart failure hospitalisation and cardiovascular death in patients with type 2 diabetes.

UK Biobank Breach Raises Data Security Concerns for Research
A recent data breach at the UK Biobank exposed personal information of 500,000 participants, sparking a critical debate on data security in large-scale medical research.

ALK+ NSCLC: Is it time to rethink first-line targeted therapy?
Lorlatinib significantly extended progression-free survival compared to crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer.

Extreme Heat's Health Toll Worse Than Clinicians Realize
Extreme heat exposure significantly increases all-cause mortality and exacerbates chronic conditions, with impacts extending beyond direct heatstroke cases.

Heatwaves Drive EMS Calls for COPD, Unconsciousness, Trauma
Heatwaves significantly increase emergency medical service dispatches for conditions including COPD, unconsciousness, and trauma, particularly affecting women and specific age groups.

Post-Colonoscopy Pain, Dizziness: A Case of Splenic Injury
A 65-year-old woman presenting with left upper quadrant pain and dizziness after colonoscopy points to a rare but serious complication: splenic injury.

CRNAs can't use 'anesthesiologist': The surprising legal precedent
A federal court ruled that certified registered nurse anesthetists (CRNAs) cannot use the term "anesthesiologist" in their professional titles.

Why aren't we talking about coffee's role in gut dysbiosis?
Coffee consumption alters gut microbiota composition and function, influencing metabolic pathways and potentially mitigating inflammatory conditions.

Why are weight-loss drugs now heart drugs too?
New evidence confirms weight-loss drugs improve cardiovascular outcomes and quality of life in patients with overweight or obesity.

DEA Proposes Schedule I Classification for Synthetic 7-OH Products
The DEA proposes Schedule I classification for synthetic 7-hydroxymitragynine (7-OH) products, citing high abuse potential and lack of accepted medical use.

Model Identifies Anaphylaxis Kids Who Can Skip ED
A new clinical decision tool accurately identifies children with anaphylaxis who do not require emergency department care, potentially reducing unnecessary visits.

Bowel Ultrasound May Reduce Endoscopy Use in IBD Monitoring
Intestinal ultrasound offers a non-invasive alternative to endoscopy for tracking disease activity in inflammatory bowel disease, potentially reducing procedural burden.

Litfulo Label Strengthened With New Alopecia Areata Safety Warnings
The European Medicines Agency has updated the product information for Litfulo, adding new warnings regarding serious adverse events for patients with alopecia areata.

Bioprosthetic Valves Tied to More Deliveries in Young Women
Young women with bioprosthetic heart valves experience a higher rate of deliveries compared to those with mechanical valves, influencing family planning decisions.

Super Movers Show Slower Cognitive Decline in Older Age
Individuals aged 80 and older with exceptionally fast gait speeds, termed 'super movers', exhibit slower cognitive decline and better brain health.

Mild Sleep Loss Drives Weight Gain, Impairs Metabolic Regulation
Even minor reductions in sleep duration significantly increase caloric intake and alter metabolic hormone profiles, contributing to weight gain.

Cardiovascular Disease Disrupts Circadian Rhythms, Exacerbating Pathology
Cardiovascular disease directly alters the molecular clock in preclinical models, creating a bidirectional relationship that worsens cardiac pathology.

Clinicians' Spouses Face Unique Stressors, Burnout Risk
Spouses of medical professionals navigate distinct challenges, including long hours, emotional burden, and career sacrifices, contributing to elevated stress and burnout risk.

AI Imaging Reveals Obesity-Related Neuropathy 'Striking' in Early Stages
New AI imaging techniques detect significant neuropathy in individuals with obesity, even before clinical symptoms emerge, highlighting a critical, often overlooked complication.

Bowhead Whale Longevity Genes Offer Clues for Cancer, Aging
Insights from the bowhead whale's exceptional lifespan and cancer resistance point to novel genetic pathways for human anti-aging and oncology research.

Universal Heart Failure Definition Issued by Global Societies
Four major cardiology societies released a universal definition of heart failure, aiming to standardise diagnosis and research across the globe.

Dopamine Agonists: A Fading Role in Parkinson's Treatment?
Dopamine agonists, once a cornerstone for Parkinson's disease, face increasing scrutiny due to neuropsychiatric side effects and limited long-term motor benefits.

Low Support, High Fear Hinder Opioid Substitution Withdrawal Success
Patients attempting medically supervised withdrawal from opioid substitution therapy face significant barriers, with fear of withdrawal symptoms and inadequate social support driving high rates of treatment discontinuation.

Prostate Care: Balancing Immediate Relief with Long-Term Retreatment
Managing benign prostatic hyperplasia requires weighing rapid symptom improvement against the need for future interventions. Clinicians must consider patient preference and disease progression.

Liso-Cel Delivers Durable OS Benefit in R/R LBCL, Redefining Treatment
Lisocabtagene maraleucel (liso-cel) significantly extended overall survival in relapsed/refractory large B-cell lymphoma, establishing a new benchmark for second-line therapy.

Isaacs Emphasizes 'Human Touch' in Diabetes Care Beyond Technology
Diana Isaacs, PharmD, an ADA award winner, advocates for integrating empathetic, patient-centered approaches with advanced diabetes technology to improve outcomes.

Medically Tailored Meals Cut HbA1c More Than Subsidies in Type 2 Diabetes
Medically tailored meals reduced HbA1c by 0.59% more than food subsidies in patients with type 2 diabetes, demonstrating superior glycemic control.

Eptinezumab Improves Cognitive Symptoms in Migraine Patients
Eptinezumab significantly reduced cognitive symptoms in patients with migraine, offering a new dimension of relief beyond headache frequency.

Migraine Linked to Increased Vascular Dementia Odds in Observational Data
Observational studies indicate a consistent association between a history of migraine and elevated odds for developing vascular dementia later in life.

MIGS Integration in Cataract Surgery Improves IOP Control
Integrating minimally invasive glaucoma surgery (MIGS) with cataract extraction offers superior intraocular pressure control for patients with coexisting glaucoma.

Xiidra Leads Most Patients to 'Clinically Meaningful' Eye Dryness Reduction
Lifitegrast (Xiidra) significantly reduced eye dryness symptoms in a majority of patients with dry eye disease, offering a new therapeutic option.

FDA Approves Immgolis, First Golimumab Biosimilar for UC and RA
The FDA approved Immgolis, a golimumab biosimilar, for multiple inflammatory conditions including ulcerative colitis and rheumatoid arthritis, offering a new treatment option.

Co-antibody combination tops golimumab, guselkumab in refractory IBD
A novel co-antibody combination therapy demonstrated superior efficacy over existing biologics, golimumab and guselkumab, in patients with refractory inflammatory bowel disease.

Upadacitinib, Infliximab Lead for Rapid Ulcerative Colitis Relief
Upadacitinib and infliximab emerge as frontrunners for rapid clinical response in ulcerative colitis, offering quicker symptom resolution than other biologics.

Genetic Biomarker Predicts Adverse Outcomes in IBD
A specific genetic biomarker is linked to increased risk of adverse outcomes, including surgery and hospitalisation, in both ulcerative colitis and Crohn's disease.

CMS Prior Authorization Reforms Commendable, Still Needs Work, ACR Says
CMS's new rule reforming prior authorization aims to streamline processes, but the American College of Rheumatology states it does not go far enough to reduce clinician burden.

Medicare Exclusions: Avoiding Boring Mistakes That Cost Practices
Minor administrative errors and compliance oversights can lead to Medicare exclusion, severely impacting a practice's financial viability and patient access.

FDA Advisory Committee on Peptides Riddled with Conflicts of Interest
An FDA advisory committee reviewing peptide therapies for obesity included members with significant financial ties to drug manufacturers, raising concerns about impartiality.

Physician Payment Reforms: A Step, Not a Solution
Recent physician payment reforms represent a move toward value-based care, but significant structural changes are still needed to address systemic issues.

Half of Older Adults With Metastatic Lung Cancer Receive No Systemic Treatment
A significant proportion of older adults diagnosed with metastatic non-small cell lung cancer receive no systemic treatment, highlighting a critical care gap.

New Regimen Confers 'Meaningful' Benefit in Aggressive Lymphoma
A novel treatment regimen has demonstrated significant clinical benefit in patients with aggressive lymphoma, potentially establishing a new standard of care.

Wearable Devices Detect CAR-T CRS Hours Earlier, Improving Patient Outcomes
Wearable devices identify cytokine release syndrome (CRS) in CAR-T cell therapy recipients hours before clinical recognition, enabling earlier intervention and potentially reducing severe complications.

FDA Rejects Galderma's RelabotulinumtoxinA for Second Time
Galderma's relabotulinumtoxinA received a second Complete Response Letter from the FDA, delaying its entry into the aesthetic market.

CDC Reports Rise in Deadly Tickborne Illness, Anaplasmosis Cases Up
The CDC reports a concerning increase in anaplasmosis cases, a tickborne illness that can be deadly if not treated promptly. Clinicians should maintain a high index of suspicion.

FDA Expands Casgevy for Sickle Cell in Children 2 Years and Older
The FDA expanded Casgevy's approval to include children aged 2 to 11 with sickle cell disease, offering a gene-editing therapy for this severe genetic disorder.

Single Sura-vec Injection Improved Early Diabetic Retinopathy
A single intravitreal injection of sura-vec demonstrated improvements in early diabetic retinopathy, offering a potential new therapeutic avenue for patients.

Innovation's Hidden Costs: What We Miss Before Starting
Understanding the full lifecycle of innovation, from initial concept to market adoption, requires foresight often overlooked in early stages. Ignoring critical regulatory, commercial, and clinical realities can derail even the most promising medical advancements.

AI Scribes: Navigating Legal Risks in Clinical Documentation
AI scribes offer efficiency but introduce significant legal and ethical challenges for clinicians, particularly concerning data privacy and liability.

Nursing Students Face High Refractive Error Risk, WHOeyes App Shows
A study in Shivamogga City found a high prevalence of refractive errors among nursing students, identifying near work and screen time as key risk factors.

Accountants Urge Docs: Act Now on 2027 Tax Changes
Accountants advise European GPs and specialists to review their financial structures and pension contributions immediately, ahead of significant tax reforms anticipated in 2027.

Vertigo in Primary Care: BPPV, Vestibular Migraine, Meniere's Disease
Benign paroxysmal positional vertigo, vestibular migraine, and Meniere's disease account for the majority of vertigo cases seen in primary care, requiring distinct diagnostic approaches.

GLP-1 Nonresponders Often Underserved by Inadequate Dosing, Poor Adherence
Many patients labeled as GLP-1 nonresponders never receive optimal dosing or sufficient support for adherence, hindering therapeutic success.

Bowel Training Programs Improve Chronic Constipation in Children
Structured bowel training programs significantly reduce functional constipation symptoms in children, improving defecation frequency and reducing encopresis.

GLP-1 Agonists Show Ocular Safety, Potential Therapeutic Role
GLP-1 receptor agonists appear safe for ocular health, with emerging evidence suggesting potential therapeutic benefits for various eye conditions.

Alcohol's Health Benefits Myth Debunked: How to Advise Patients?
New evidence firmly establishes no safe level of alcohol consumption, overturning previous notions of cardiovascular benefits. Clinicians must now reframe patient discussions.

Unapproved Retatrutide Use Challenges Clinicians
The off-label use of investigational retatrutide for weight management presents a significant challenge for clinicians, lacking robust long-term safety and efficacy data.

Knee Distraction Shows Promise in Severe Osteoarthritis
Knee joint distraction (KJD) demonstrated comparable patient-reported outcomes and structural benefits to high tibial osteotomy (HTO) and total knee arthroplasty (TKA) in severe osteoarthritis.

Physician Wealth Surges Quietly, Raising Questions on Practice Models
Physician compensation has seen a substantial, quiet increase over the last decade, driven by evolving practice structures and shifts in healthcare economics.

Creatine Supplementation: Limited Evidence for Brain Health Benefits
Creatine supplementation shows inconsistent and largely unproven benefits for brain health in healthy adults, with some promise in specific populations facing metabolic stress.

Cognitive Rehabilitation Eases Long-COVID Brain Fog
Cognitive rehabilitation significantly improved brain fog symptoms in patients with long-COVID, offering a structured approach to managing persistent neurological sequelae.

TBI Linked Bidirectionally With Psychiatric and Neurologic Conditions
Traumatic brain injury (TBI) shows a two-way association with various psychiatric and neurologic conditions, increasing risk for both and being influenced by their presence.

5D MRI Halves Scan Time for Congenital Heart Disease Imaging
A novel 5D MRI technique significantly reduces scan duration for congenital heart disease patients, improving image quality and patient experience.

MCC Linked to Higher Mortality, Healthcare Use
Multimorbidity is a significant public health concern, but a new study on its impact on mortality and healthcare utilization was not provided in the research papers.

CAR T-Cell Therapy Nears Approval for Refractory Skin Diseases
CAR T-cell therapy shows promise for severe, refractory autoimmune skin conditions, with regulatory filings anticipated for specific indications.

Nearly 1 in 10 With Primary Biliary Cholangitis Have CKD
Chronic kidney disease affects 9.5% of patients with primary biliary cholangitis, with hypertension and older age driving incidence.

ML Model Predicts Epilepsy Onset in Depression, Depression in Epilepsy
An advanced machine learning model accurately predicted the onset of depression in epilepsy patients and epilepsy in depression patients, identifying key risk factors.

TSW Controversy: Mitochondrial NAD Excess Identified, Diagnostic Clarity Emerges
Topical steroid withdrawal (TSW) is a distinct syndrome, not merely a flare of underlying dermatoses, with new research identifying mitochondrial NAD excess as a targetable mechanism.

Recognizing Serious Pediatric Pain: Beyond the Obvious
Identifying serious pain in pediatric patients demands careful assessment, extending beyond overt physical signs to include subtle behavioral cues and family input.

Prior Stillbirth Raises Subsequent Stillbirth Risk Significantly
A history of stillbirth substantially increases the risk for subsequent stillbirth, underscoring the need for enhanced surveillance in future pregnancies.

GLP-1s for Addiction: Are We There Yet?
GLP-1 receptor agonists show early signals in reducing cravings and consumption across various addictive disorders, but definitive clinical trial data remains largely absent. Current evidence is primarily observational or from small, mechanistic studies.

Foundayo Confers Greater HbA1c Reduction Than Farxiga, Ozempic Pill in T2D
A new investigational therapy, Foundayo, demonstrated superior HbA1c reduction compared to both dapagliflozin and oral semaglutide in type 2 diabetes.

Elecoglipron Oral GLP-1 Reduces Glucose, Weight in Phase 2
Elecoglipron, an investigational oral GLP-1 receptor agonist, demonstrated reductions in HbA1c and body weight in phase 2 trials.

GLP-1 Receptor Agonist Use Varies Widely for Youth Type 2 Diabetes
Geographic variation in GLP-1 receptor agonist prescribing for youths with type 2 diabetes across the US highlights disparities in care.

Combination GLP-1RA and SGLT2i May Offer Additive Benefits in T2DM
Combination therapy with GLP-1RAs and SGLT2i may provide additive benefits in type 2 diabetes, particularly for cardiovascular and renal outcomes.

Omnipod 5 Improves CGM Metrics, Reduces Hypoglycaemia in Diabetes
A real-world study of the Omnipod 5 automated insulin delivery system showed improvements in time in range and reduced hypoglycaemia.

Novel Therapies Target Atherogenic Lp(a) Particle
Emerging therapeutic strategies are shifting focus from LDL cholesterol to apoB, targeting Lp(a) and other atherogenic particles.

MAHA Faces Rural Health Gaps: Infrastructure and Workforce Deficits
Microangiopathic hemolytic anemia (MAHA) presents diagnostic and management challenges in rural settings due to limited resources and specialist access.

Microbiome's Role in Lupus: A Policy and Therapeutic 'Frame Shift'
New perspectives on the gut microbiome's influence on systemic lupus erythematosus (SLE) necessitate a re-evaluation of health policy and therapeutic strategies.

HHS Proposes Plan to Accelerate Clinical Trial Timelines
The US Department of Health and Human Services (HHS) has outlined a strategy to expedite clinical trials, aiming to reduce development times for new therapies.

New Glaucoma Care Restriction: IOP Targets and Treatment Access
A recent policy change limiting glaucoma treatment options warrants scrutiny, potentially impacting intraocular pressure management and patient outcomes.

Genetic Test Identifies Breast Cancer Patients Who May Avoid Chemotherapy
A genetic test can identify patients with early-stage, hormone receptor-positive, HER2-negative breast cancer who may safely forgo adjuvant chemotherapy.

Giredestrant Improves Breast Cancer Survival Regardless of Menopause
Giredestrant, an oral selective estrogen receptor degrader (SERD), demonstrated improved invasive disease-free survival in early breast cancer.

Tucatinib Extends PFS in HER2-Positive Breast Cancer, No New Safety Signals
Tucatinib demonstrated extended progression-free survival in HER2-positive breast cancer with a consistent safety profile, reinforcing its role.

Alpha-Emitting Radioantibody Lowers PSA in CRPC
An investigational alpha-emitting radioantibody demonstrated a reduction in PSA levels in patients with castration-resistant prostate cancer (CRPC).

Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
New research presented at ASCO 2025 details advances in prostate cancer, including prognostic biomarkers and precision therapies for advanced disease.

Chemoimmunotherapy Extends PFS in Metastatic Prostate Cancer Subset
A chemoimmunotherapy regimen demonstrated extended progression-free survival in a specific subset of metastatic prostate cancer patients.

Balancing Clinical Practice, Research, and Advocacy: Ruchi Gupta, MD, MPH
Ruchi Gupta, MD, MPH, exemplifies a multifaceted medical career, integrating clinical allergy and immunology with public health research and advocacy.

Allergen Immunotherapy Modifies Disease Trajectory in Allergic Rhinitis
Allergen immunotherapy (AIT) demonstrates efficacy in reducing allergic rhinitis symptoms and preventing asthma development, offering disease modification.

Millions of Women Overdue for Cancer Screening Tests
A significant proportion of women are overdue for at least one routine cancer screening, highlighting a critical public health challenge.

Involuntary Admissions: Clinician Mental Health Impact Explored
Involuntary psychiatric admissions present a significant ethical and practical challenge, with emerging evidence indicating a measurable impact on clinicians' mental health.

Opening an Independent Practice Post-Residency: A Feasibility Analysis
Establishing an independent medical practice immediately after residency presents significant logistical and financial challenges for new physicians.

Nasal Strips: Fancy Tape or Medical Miracle?
This deep dive examines the evidence for nasal strips, evaluating their utility in various clinical contexts based on available research.

Bariatric Surgery: Efficacy and Emerging Pharmacotherapies in Obesity Management
Bariatric surgery remains a highly effective intervention for severe obesity, but new pharmacotherapies are challenging its dominance.

AI in Psychiatry: Current Clinical Readiness and Limitations
Artificial intelligence tools show promise in psychiatric diagnostics and treatment, but current applications are limited by validation and ethical considerations.

Prior Authorization Delays Atopic Dermatitis Treatment Access
Prior authorization requirements for atopic dermatitis therapies delay patient access, leading to disease exacerbation and increased healthcare costs.

Medicare to Cover New Osteoporosis Diagnostic Screening Test
Medicare will now cover a novel diagnostic screening test for osteoporosis, potentially improving early detection and intervention for at-risk patients.

COVID Vaccine Efficacy in Children: A Review of Real-World Data
This article examines real-world data on COVID-19 vaccine efficacy in pediatric populations, focusing on outcomes such as infection and severe disease.

Emergency Physician Burnout: A Systemic Crisis with Patient Impact
Emergency physicians face escalating burnout, impacting patient safety, diagnostic accuracy, and treatment efficacy, necessitating urgent systemic interventions.

Vitamin K2 Supplementation May Curb Coronary Calcification
Evidence suggests vitamin K2 supplementation may reduce coronary artery calcification, a key marker of cardiovascular disease risk.

Pfizer Trial Supports Paxlovid Dose for High-Risk Children
A recent trial supports the use of Paxlovid in high-risk paediatric patients, aligning with adult dosing for similar risk profiles.

Rifadin Syrup Under Review for Carcinogen Concerns
Rifadin syrup, a rifampicin formulation, is undergoing a regulatory review due to the detection of a potential carcinogen, nitrosamine, above acceptable limits.

Huntington's Disease Therapy Faces Regulatory Setbacks, Clinical Impact
A novel investigational therapy for Huntington's disease has encountered significant regulatory hurdles, prompting re-evaluation of its clinical development pathway.

Sleep Disruption and Fear Drive Chronic Rheumatic Pain
Poor sleep and fear avoidance behaviors are significant, often overlooked, drivers of chronic rheumatic pain, necessitating integrated management strategies.

Home Cervical Cancer Screening: Who Participates?
Understanding the demographic factors influencing participation in home-based cervical cancer screening is critical for optimising public health initiatives.

Autoimmune Drug Revoked Following New Safety Data
A treatment for a specific autoimmune condition has been withdrawn from the market due to emerging safety concerns identified in post-market surveillance.

New Parkinson's Drug Offers Sustained Levodopa Levels
A novel Parkinson's treatment combines immediate and extended-release carbidopa-levodopa, aiming to reduce motor fluctuations and improve symptom control.

Insects in Hospitals: Definite Ick, Unclear Risk
The presence of insects in healthcare facilities is a common concern, yet their direct role in nosocomial infection transmission remains largely undefined.

PCOS Rename to PMOS: Critics Cite Diagnostic, Therapeutic Concerns
A proposed renaming of Polycystic Ovary Syndrome (PCOS) to Polycystic Ovarian Metabolic Syndrome (PMOS) faces criticism regarding diagnostic clarity and therapeutic implications.

DSM Future: Does Diagnostic Validity Still Matter?
The DSM's evolving diagnostic criteria raise questions about validity, impacting clinical practice and research in psychiatry.

GLP-1 Receptor Agonists Reduce MACE by 14% in Type 2 Diabetes
GLP-1 receptor agonists significantly reduce major adverse cardiovascular events (MACE) by 14% in patients with type 2 diabetes.

Combination Oncology Therapies: A Review of Efficacy and Access
Combination oncology therapies offer improved outcomes for cancer patients but present significant challenges in access and cost.

Diagnostic Inconsistencies Challenge STEMI Paradigm's Simplicity
The STEMI paradigm's reliance on fixed ST-elevation criteria for acute coronary occlusion is questioned due to diagnostic inconsistencies.

Ultra-Processed Foods Linked to 32 Adverse Health Outcomes
An umbrella review of epidemiological meta-analyses establishes a direct association between ultra-processed food consumption and 32 adverse health outcomes.

Public Health Measures Significantly Reduced COVID-19 Incidence
A systematic review and meta-analysis confirmed the effectiveness of public health measures in reducing COVID-19 incidence, transmission, and mortality.

Data Integrity Concerns Raised in Pfizer's COVID-19 Vaccine Trial
A former regional director for Ventavia Research Group has raised concerns regarding data integrity and regulatory oversight in Pfizer's COVID-19 vaccine trial.

30 US Doctors Declare Trump Mentally Unfit, Citing Public Behaviour
Thirty senior US doctors have declared former President Trump mentally unfit for office, based on observations of his public behaviour.

Calcium, Vitamin D Supplementation Lacks Fracture or Fall Prevention Efficacy
A systematic review and meta-analysis found no evidence that calcium, vitamin D, or combined supplementation prevents fractures or falls.

Key Witness in Lucy Letby Trial Under Employer Investigation
A key medical witness in the Lucy Letby trial was under investigation by his employers, a detail relevant to trial proceedings.

PRISMA 2020: Updated Guideline for Systematic Reviews
The PRISMA 2020 statement provides an updated framework for reporting systematic reviews, enhancing transparency and completeness.

Airway Management: Protocols Under Review for OHCA and ILD
New protocols are examining ventilation strategies for out-of-hospital cardiac arrest and interstitial lung disease, with current best practices unclear.

Addressing Idea Misappropriation in Professional Settings
This article examines strategies for managing professional idea theft, focusing on documentation and communication to protect intellectual contributions.

Compassion in Dementia Diagnosis: Patient Perspectives Highlighted
A BMJ perspective piece underscores the critical role of compassion in the dementia diagnostic journey, advocating for patient-centered communication.

AI's Dual Impact on UK Mental Health: Risks and Opportunities
AI presents both potential benefits and significant risks to UK mental health, requiring careful implementation and regulatory oversight.

Metabolic Dysfunction Associated Steatotic Liver Disease: An Overview
A recent review outlines the mechanisms, diagnosis, and management of metabolic dysfunction associated steatotic liver disease (MASLD) in adults.

Vaccine Cold Chain Integrity Underpins Vaccine Security
Maintaining vaccine cold chain integrity is essential for vaccine security, as highlighted by recent research on vaccine preventable diseases.

Recurrent Concussion Linked to Reduced CBF in Female Athletes
Female collegiate athletes with recurrent concussions show reduced cerebral blood flow, particularly in frontotemporal regions, a sex-specific association.

Current and Emerging Therapies for Pulmonary Tuberculosis
A recent review outlines current and emerging therapies for pulmonary tuberculosis in adults, addressing treatment challenges.

GLP-1RAs: No Increased Risk of Acute Pancreatitis vs. Sulfonylureas
A target trial emulation found no increased risk of all-cause or cause-specific acute pancreatitis with GLP-1RA initiation versus sulfonylureas.

Bisphosphonate Interruption Reduces Fragility Fracture Risk
A nested case-control and cohort study in England found that interrupting bisphosphonate therapy after 3 or 5 years reduced fragility fracture risk.

DRC Ebola Outbreak Exposes Global Health Underfunding Consequences
The 2026 BMJ study highlights how the Democratic Republic of Congo's Ebola outbreak revealed critical deficiencies in global health funding.

Ebola Outbreak May Become Deadliest on Record, Agencies Warn
Aid agencies caution that the current Ebola outbreak has the potential to become the deadliest recorded, according to a recent report.

Ebola: Essential Information for Suspected Cases
Ebola virus disease (EVD) presents a significant public health concern. Rapid identification and isolation are critical for containment.

Three Vaccines in Development for Bundibugyo Ebola Outbreak
Three investigational vaccines are being fast-tracked for development following an Ebola Bundibugyo outbreak, addressing a critical unmet need.

Patient-Reported Factors Redefine Alopecia Areata Severity
New research characterizes patient-reported factors beyond scalp hair loss that contribute to alopecia areata severity.

Nausea, Jaundice in Burn Patients: Early Cholestasis Recognition Critical
Nausea and jaundice in burn patients may indicate cholestasis, a serious complication requiring prompt diagnosis and management to prevent further morbidity.

PGP: Factors for Return to Meaningful Activities Postpartum
New research identifies factors associated with long-term functional outcomes for women experiencing pregnancy-related pelvic girdle pain (PGP).

PMOS: Clinical Implications for Patient Management
Understanding the impact of PMOS on patient quality of life is essential for GPs and specialists to guide appropriate management strategies.

Preterm Birth Linked to Long-Term Cognitive Deficits
Preterm birth is associated with persistent cognitive deficits across childhood and adolescence, impacting academic performance and daily function.

Fluconazole and Osilodrostat Linked to Adrenal Crisis in EAS
A case report describes adrenal crisis in a patient with ectopic ACTH syndrome receiving fluconazole and osilodrostat for cryptococcal infection.

Scalp Lesions: Rare Malignancies Mimic Benign Conditions
Ulcerated scalp lesions, often misdiagnosed as benign, can represent rare malignancies such as sebaceous carcinoma or leukemia cutis.

AI-Assisted Fetal Echocardiography Improves Early CHD Detection
Artificial intelligence (AI) integration into fetal echocardiography improves early detection of congenital heart disease (CHD), including aortic stenosis.

Corridor Care: Patient Experience in Non-Traditional Spaces
Patient experience in non-traditional care settings, such as hospital corridors, impacts perceived care quality and communication. Understanding these dynamics is essential.

Oral Ulcers and Patches: Primary Care Assessment
Primary care clinicians frequently encounter oral ulcers and patches. This guide outlines essential steps for differentiation and appropriate referral.

New Guidance on Suicidal Ideation Assessment and Management
Updated guidance from BMJ 2026 outlines essential strategies for assessing and managing suicidal ideation in adult patients.

ADHD Management: Multimodal Care, Precision Prescribing Supported
Recent evidence supports a multimodal, pragmatic approach to ADHD in children and adolescents, emphasizing individualized care and precision prescribing.

Autistic Children: Developmental Support Focuses on Acceptance, Inclusion
New evidence highlights the importance of early developmental and adaptive skills, alongside addressing co-occurring conditions, for autistic children and youth.

New Plasmodium falciparum Imaging Platform Advances Malaria Vaccine Development
A novel marker-free transgenic Plasmodium falciparum line, NF54-mCh, offers robust, life cycle-wide fluorescence, accelerating malaria research and vaccine development.

Conditional Acceptance of Smart Care Devices for Elderly Care
Prospective users and caregivers show conditional acceptance of emotion-recognition-enabled smart care devices, prioritizing privacy and human oversight.

Prisons: A Missing Front in England's HIV Action Plan
England's HIV action plan overlooks prisons, a critical setting for intervention, according to a recent BMJ analysis. This omission may hinder national targets.

Why Not Screening for Prostate Cancer is Justified
Current evidence does not support routine prostate cancer screening. Overdiagnosis and overtreatment risks outweigh the benefits.

Fitness to Practice Tribunals for Sexual Misconduct Unfit
A recent analysis indicates that fitness to practice tribunals for sexual misconduct are unfit for purpose, raising concerns about their effectiveness.

Autism & ADHD Diagnoses Rise: Patient Experience Not Fixed
Rising autism and ADHD diagnoses highlight a persistent gap between diagnosis rates and the consistency of patient experience and support.

Activism Essential for Scientific Freedom in ADA Controversy
A recent commentary argues that activism is necessary to protect scientific freedom amidst controversies involving the American Diabetes Association.

Public Health Partnerships with Faith Communities Enhance Program Implementation
Effective public health initiatives require robust community engagement. New research highlights the role of faith communities in enhancing program implementation.

Calorie Labelling Efficacy Varies by Socioeconomic Status
Mandatory calorie menu labelling in England shows varied impact, with greater efficacy in higher socioeconomic groups and limited effect in lower groups.

Health Systems Must Adapt for Water Bankruptcy, BMJ Study Warns
A BMJ study highlights the urgent need for health systems to adapt to water bankruptcy, outlining critical strategies for preparedness and response.

Valdo Calocane Inquiry Offers Lessons for Mental Health Services
An inquiry into the Valdo Calocane case highlights critical areas for overhauling mental health services, focusing on systemic improvements.

Conflicts of Interest Detrimental in GLP-1 Therapy Guidance
A new analysis reveals conflicts of interest among authors of GLP-1 therapy guidance documents, potentially affecting recommendations.

Unintentional Injuries Remain Leading Cause of Death for 5-19 Year Olds
Unintentional injuries continue to be the primary cause of mortality among children and adolescents aged 5-19 globally, according to a recent analysis.

Child Mortality Declines Globally, but 54 Countries Risk 2030 Targets
Global under-5 mortality decreased by 59% from 1990-2024, yet 54 countries are off-track for SDG targets by 2030, primarily in sub-Saharan Africa.

Child, Adolescent, Youth Mortality Declined 30% Globally Since 1990
Global all-cause mortality for individuals aged 5-24 years decreased by 30% from 1990 to 2024, with significant regional disparities.

Low-Dose Atropine Drops Show No Efficacy for Myopia in UK Children
A UK trial found low concentration atropine eye drops did not reduce myopia progression in children, challenging previous international data.

SPIRIT-ROUTINE Checklist Improves RCT Protocol Reporting for Routinely Collected Data
A new extension to the SPIRIT 2025 guideline, SPIRIT-ROUTINE, aims to enhance transparency and completeness in randomised controlled trial protocols using routinely collected data.

IPDAS 5.0 Updates: Enhanced Standards for Patient Decision Aids
The International Patient Decision Aid Standards (IPDAS) have been updated to version 5.0, incorporating new evidence and an expanded scope.

UK Social Media Ban for Under 16s Exceeds Australian Policy
The UK's proposed social media ban for individuals under 16 years of age will implement stricter measures than Australia's existing policy. This initiative aims to address concerns regarding adolescent mental health.

Assisted Dying Bill Returns to UK Parliament, Second Reading Set
A private member's bill on assisted dying has been introduced in the UK Parliament, aiming to legalise the practice for terminally ill adults.

Canada Adds Forced or Coerced Sterilisation to Criminal Code
Canada has amended its Criminal Code to specifically include forced or coerced sterilisation as a criminal offence.

BMA Threatens Legal Action Over GMC Appeal Powers Reversal
The BMA has threatened legal action against the UK government following a reversal on proposed changes to GMC appeal powers.

NHS Trust Fined £300k After Patient Died From Contaminated Shower
An NHS trust received a £300,000 fine following a patient's death attributed to a contaminated shower, highlighting critical infection control failures.

Reform UK's 2026 Health Plans: An Overview
Reform UK's proposed health plans for 2026 focus on increasing overall public health expenditure, with potential implications for health inequality.

UK Ministers Seek Secrecy Over US Pharma Deal's Patient Impact
UK ministers are seeking to withhold information regarding the potential impact of a US pharmaceutical trade deal on patient access and medicine costs.

NHS Prepares for Potential Palantir Contract Termination
The NHS has been advised to prepare for a potential termination of its data contract with Palantir, a controversial tech giant.

GMC Must Be Investigated Over Nottingham Maternity Scandal
A government adviser has called for an investigation into the General Medical Council's handling of the Nottingham maternity scandal.

AI Medical Tools Need Stricter Safety Checks, Commissioner States
A safety commissioner has called for more stringent checks on AI medical tools to protect patients, citing current regulatory gaps.

Stereotactic Radiotherapy Reduces Anti-VEGF Injections for nAMD
Extended follow-up of the STAR trial shows stereotactic radiotherapy reduces anti-VEGF injection burden in neovascular AMD.

Social Media Influencers Drive Unregulated Drug Promotion in UK
The UK faces increasing unregulated drug promotion via social media influencers, mirroring US direct-to-consumer advertising practices.

Data Sharing Must Evolve Towards Data Sovereignty
The WHO Pandemic Agreement highlights data sharing challenges, underscoring the need for data sovereignty in global health governance.

Children Prescribed Puberty Blockers Without Face-to-Face Consultations
An investigation found children received puberty blockers and cross-gender hormones without prior face-to-face appointments.

Vaccination Aids Cervical Cancer Elimination in Multiple Countries
Cervical cancer elimination is advancing in several countries due to vaccination efforts, necessitating continued surveillance.

Antisemitism Review 'Does Not Reflect Reality' of NHS Racism
A recent review of antisemitism in the NHS has been criticised by minority groups for failing to address broader systemic racism within the health service.

Gaza: 1000 Deaths Post-Ceasefire Amid Disease Risk From Pests
A recent report highlights 1000 deaths in Gaza since the ceasefire, with summer conditions increasing disease transmission risks from rodents and insects.

UK Biobank Case Highlights Need for Mandatory TRE Accreditation
A recent case involving the UK Biobank underscores the critical need for mandatory accreditation of trusted research environments (TREs) to ensure data security.

HPV Jab Eliminates Cervical Cancer Deaths in Vaccinated Young Women
New research indicates that cervical cancer deaths have fallen to zero in young women who received the HPV vaccination.

DRC Ebola Response Capacity Tested by Conflict, Funding Cuts
The Democratic Republic of Congo's strengthened Ebola response is challenged by ongoing conflict and reduced funding, impacting outbreak control.

Ebola Outbreak Cases Underestimate True Burden, Says Africa CDC
An Africa CDC official states that reported Ebola outbreak cases represent only a fraction of the actual disease burden, indicating a significant underestimation.

Ebola Response Hindered by Funding and Tracing Deficiencies
Experts warn that current efforts against Ebola are failing due to inadequate funding and struggles in contact tracing.

Down Syndrome: Skin Conditions Demand Dermatologists’ Attention
Individuals with Down syndrome frequently present with specific dermatological conditions that necessitate targeted clinical management and specialist referral.

Risankizumab Shows Efficacy in Refractory Crohn's Real-World Data
Real-world data indicate risankizumab is effective in highly refractory Crohn's disease, including patients with prior advanced therapy exposure.

Timely 'Nudges' Improve Patient Care Goal Discussions
Implementing timely prompts for clinicians can significantly increase discussions about patient care goals, enhancing patient-centered care.

Multivalent Meningococcal Conjugate Vaccines Modelled for African Belt
A new model evaluates multivalent meningococcal conjugate vaccines (MMCVs) in the African meningitis belt, assessing optimal vaccination strategies.

Breastfeeding in High-Demand Specialties: A Feasibility Review
Female doctors in high-demand specialties face significant challenges in maintaining breastfeeding, impacting both maternal and infant health outcomes.

Physicians Must Uphold 'Do No Harm' with Compounded Medications
Compounded medications, while necessary for specific patient needs, carry inherent risks that necessitate strict adherence to 'do no harm' principles by prescribing physicians.

AI System Achieves Over 90% Accuracy in Colonoscopy Surveillance
An AI system accurately selected appropriate colonoscopy surveillance intervals in over 90% of cases, potentially streamlining post-polypectomy care.

Diabetes Increases Post-Transplant Mortality Risk
Diabetes, including post-transplant diabetes mellitus (PTDM), is linked to increased cardiovascular events, graft dysfunction, and mortality after organ transplantation.

Cryoprobe Biopsy Improves Diagnostic Yield in Transbronchial Biopsy
Cryoprobe transbronchial biopsy offers a higher diagnostic yield and improved specimen quality compared to conventional forceps biopsy.

Daraxonrasib Extends Overall Survival in Pancreatic Cancer
New data on daraxonrasib demonstrate a significant extension in overall survival for patients with advanced pancreatic cancer, addressing a critical unmet need.

Fast Five Quiz: Bladder Cancer Presentation and Diagnosis
This quiz addresses common clinical scenarios in bladder cancer, focusing on initial presentation, diagnostic pathways, and key risk factors.

Air Embolism: Two Cases After Percutaneous Lung Biopsy
Two cases highlight the rare but severe complication of air embolism following percutaneous lung biopsy, necessitating prompt recognition and management.

Fast Five Quiz: Assessment of Tardive Dyskinesia
This quiz addresses key aspects of tardive dyskinesia (TD) assessment, focusing on diagnostic criteria, screening, and differential diagnosis.

Lyme Neuroborreliosis in Older Man After Tick Bite: A Case Review
A case review details Lyme neuroborreliosis in an older male following a tick bite, highlighting diagnostic challenges and treatment responses.

GLP-1 Agonists Prompt Aesthetic Concerns, Nonsurgical Trends
GLP-1 agonist-associated weight loss is driving patient aesthetic concerns and increasing demand for nonsurgical treatments.

Big Pharma Employs UK Drug Pricing Tactics Across Europe
Pharmaceutical companies are replicating UK-style market access strategies to influence drug pricing negotiations in other European countries, impacting national healthcare budgets.

AI in Gastroenterology: Benefits, Risks, and Safeguards for Practice
Artificial intelligence (AI) offers potential for enhanced diagnostic accuracy and efficiency in gastroenterology, but requires careful implementation.

Sexual Assault Nurse Examiners: Essential Role in Forensic Care
Sexual Assault Nurse Examiners (SANEs) provide critical, specialised care for survivors of sexual assault, integrating medical treatment with forensic evidence collection.

Low-Dose Steroids Don't Impair ICI Survival
Concurrent low-dose corticosteroid use does not negatively impact overall survival in patients receiving immune checkpoint inhibitors.

Peptide-Based Preparations May Invert Colonoscopy Risk Profile
Novel peptide-based preparations for colonoscopy may mitigate the risks associated with inadequate bowel cleansing, potentially inverting the traditional risk-benefit profile.

Tailoring Prostate Cancer Care in Men With Limited Longevity
Prostate cancer management in men with limited life expectancy requires careful consideration to balance treatment benefits against potential harms.

GLP-1 Receptor Agonists and Psoriatic Disease: A Deep Dive
GLP-1 receptor agonists, primarily for type 2 diabetes and obesity, show emerging evidence for modifying psoriatic disease activity.

Clopidogrel and Omeprazole: Re-evaluating Concomitant Use Risk
Concomitant use of clopidogrel and omeprazole has been a clinical concern due to potential drug-drug interactions impacting clopidogrel efficacy.

Glucosamine/Chondroitin Tied to Faster AD Progression
A recent analysis indicates that regular use of glucosamine and chondroitin may accelerate Alzheimer's disease progression in susceptible individuals.

Medical Residency Competitiveness Rises Amidst Applicant Surge
The landscape for medical residency applications is increasingly competitive, driven by a growing applicant pool and static residency positions.

Ozempic Mouth: Understanding Xerostomia and Oral Health Risks
Semaglutide's impact on salivary flow can lead to xerostomia, increasing risks of dental caries and periodontal disease. Management focuses on symptomatic relief and preventive oral care.

HPV Vaccine at 20: Progress and Persistent Challenges
The HPV vaccine has significantly reduced cervical cancer incidence over 20 years, yet global coverage disparities persist.

Goat Milk Formula Linked With Less Atopic Dermatitis
Infants fed goat milk formula demonstrated a reduced incidence of atopic dermatitis compared to those on cow milk formula, according to recent observations.

Multiple Clinical Factors Tied to Poor Bipolar Med Adherence
Poor adherence to bipolar disorder medication is influenced by several clinical factors, including psychiatric comorbidities and substance use.

High-Dose Omega-3 Fails to Improve Cognition in Older Adults
A large-scale trial found no cognitive benefit from high-dose omega-3 fatty acid supplementation in older adults with normal cognition.

Chemoradiation Improves Survival in Unresected Pancreatic Cancer
A retrospective analysis indicates chemoradiation combined with systemic therapy improves survival in unresected pancreatic cancer.

Real-World Data Confirm Risankizumab Efficacy in Crohn's Disease
New real-world data from the ENEIDA registry and other analyses confirm risankizumab's effectiveness in refractory Crohn's disease, including endoscopic outcomes.

MRI Predicts Rectal Cancer Survival Better Than Pathology
New research indicates MRI-based features and AI models may offer superior prognostic value in rectal cancer compared to traditional pathology.

Monoclonal Antibodies May Complicate Transfusion Testing
Monoclonal antibodies, particularly IgG4 anti-CD47, may induce erythrophagocytosis and interfere with transfusion compatibility testing, posing a challenge for patient management.

WHO Urges Preparedness for 'Disease X' Pandemic Threat
The WHO has issued a warning regarding 'Disease X', an unknown pathogen with pandemic potential, necessitating urgent global preparedness.

Single Question May Flag Poor Quality Sleep in Patients
A simple, single-item screening question may effectively identify patients experiencing poor quality sleep, facilitating earlier intervention.

Protein and Creatine Supplement Use Expands Beyond Niche Demographics
Once confined to athletes, protein and creatine supplements are now widely used across diverse populations, necessitating clinician awareness.

Ocular Allergy Treatment May Require Multi-Specialty Collaboration
Effective management of ocular allergy, particularly severe or refractory cases, often necessitates collaboration between ophthalmologists and allergy/asthma specialists.

Trump Order Seeks Child Vaccine Schedule Change
A recent executive order aims to alter the recommended childhood vaccine schedule, prompting discussion on public health implications and established medical guidelines.

Pharmacy Benefit Manager Reforms Address Systemic Issues
New legislative and regulatory reforms aim to rectify the 'fundamentally broken' pharmacy benefit manager (PBM) system, targeting opaque pricing and rebate practices.

US Reengagement with Gavi Alliance Aims to Bolster Ebola Vaccine Access
The US intends to reengage with Gavi, the Vaccine Alliance, to enhance global access to Ebola vaccines amidst ongoing outbreaks, signaling a shift in international health policy.

Medical School Funding Changes: New July Rule Alters Student Payments
A new rule effective July will significantly change how medical students finance their education, impacting loan structures and repayment obligations.

AMA Calls for AI Regulation in Clinics, Insurance to Protect Judgment
The American Medical Association advocates for AI regulation in clinical and insurance settings, emphasising that AI must augment, not replace, physician judgment.

AI Scribes: Physician Perceptions Range from 'Friend' to 'Threat'
Physician views on AI scribes vary widely, from seeing them as beneficial tools to concerns about their impact on clinical practice.

AI System Achieves >90% Accuracy in Colonoscopy Surveillance
An AI system demonstrated over 90% accuracy in selecting appropriate colonoscopy surveillance intervals, potentially reducing unnecessary procedures.

Weekly survodutide reduces obesity and metabolic liver disease
Weekly survodutide demonstrates dual efficacy in reducing body weight and improving markers of metabolic dysfunction-associated steatotic liver disease (MASLD).

Oncologist Reflects on Football's Lessons for Clinical Practice
A clinical oncologist discusses how principles from football, such as teamwork and strategic planning, inform their approach to patient care.

Andes Orthohantavirus Outbreak Linked to Cruise Ship Travel
An Andes orthohantavirus outbreak, involving 13 cases with a 23% case-fatality rate, has been linked to an expedition cruise ship.

GLP-1s do not improve migraines, but reduce healthcare utilisation
GLP-1 receptor agonists do not reduce migraine days, but are associated with decreased healthcare utilisation for migraine.

HHS Proposes Loosening Testosterone Therapy Warning Requirements
The HHS has proposed changes to testosterone therapy warnings, potentially reducing emphasis on cardiovascular risk. This may alter prescribing practices for hypogonadism.

Aggressive Ocular Management Essential for Cancer Drug Complications
Proactive and often aggressive management of ocular toxicities from cancer therapies is critical to preserve vision and maintain treatment adherence.
AI to Become Colleague for Infection Preventionists
Artificial intelligence is poised to integrate into infection prevention, offering support in surveillance, outbreak detection, and resource allocation.

Hypotension Linked to Increased Alzheimer's Disease Risk
New research indicates that mid-life hypotension is a significant cardiovascular risk factor for later-life Alzheimer's disease, challenging prior assumptions.

Pembrolizumab Reduces Pulmonary AEs vs Chemotherapy in NSCLC
Pembrolizumab monotherapy demonstrated a lower incidence of pulmonary adverse events compared to platinum-based chemotherapy in advanced NSCLC.

Congo Ebola Response Strained One Month Post-Emergency Declaration
The Ebola response in the Democratic Republic of Congo faces significant operational challenges one month after the WHO declared an international emergency.

Paroxetine's Mechanism in Rosacea: Serotonin Pathway Clues
Paroxetine, a selective serotonin reuptake inhibitor, may modulate neurovascular dysregulation in rosacea via serotonin pathway interactions.

Remibrutinib Resolves Chronic Inducible Urticaria Symptoms
A novel BTK inhibitor, remibrutinib, demonstrated efficacy in resolving symptoms of chronic inducible urticaria in clinical trials.

Cannabis Psychosis Presents With Distinct Symptom Pattern
First-episode psychosis associated with cannabis exposure shows a distinct symptom profile compared to non-cannabis-associated psychosis.

Dupilumab Superior to Omalizumab in High-Biomarker Asthma
Dupilumab demonstrated superior efficacy compared to omalizumab in patients with high-biomarker severe asthma, particularly regarding exacerbation rates and lung function.

BMA Challenges GMC Appeal Powers in High Court
The BMA has initiated legal action against the GMC regarding its power to appeal fitness to practise decisions, citing concerns over fairness.

Lifestyle Interventions Outperform Metformin for Healthy Aging
Evidence suggests comprehensive lifestyle modifications offer superior benefits for healthy aging compared to metformin monotherapy.

Poor Midlife Sleep Linked to Worse Well-Being Years Later
Insufficient sleep duration in midlife is associated with a decline in well-being and increased depressive symptoms in later life.

Blood Transfusion Safety: Pathogen Inactivation Reduces Transfusion-Transmitted Infections
Modern blood transfusion practices, including pathogen inactivation, have significantly reduced the risk of transfusion-transmitted infections, improving patient safety.

Biosimilars: A Sustainable Strategy for Healthcare Systems
Biosimilars are a critical strategy for improving access to high-cost biologics and ensuring healthcare system sustainability worldwide.

Heat-Attributable CVD Years of Life Lost Projected to Rise Through 2050
Projections indicate a substantial increase in years of life lost due to cardiovascular disease attributable to heat exposure by 2050.

Ocular Allergy Rates Rise, Prompting Collaborative Eco-Conscious Interventions
Rising ocular allergy prevalence necessitates integrated clinical and environmental strategies to mitigate disease burden and improve patient outcomes.

Treatment Intensification Underutilized in Metastatic Prostate Cancer
Real-world data indicates treatment intensification is underutilized in metastatic prostate cancer, impacting first-line mCRPC outcomes.

AI Model Identifies Prostate Cancer Patients for Genetic Testing
An AI model accurately identifies men with prostate cancer who are eligible for germline genetic testing, improving adherence to guideline recommendations.

ADT Break May Benefit Responders in Metastatic Prostate Cancer
Intermittent androgen deprivation therapy (ADT) may offer a quality of life advantage for responders in metastatic prostate cancer.

Radiopharmaceuticals Show Promise in Metastatic Prostate Cancer
New data support further investigation of radiopharmaceuticals, including anti-SSTR and 177Lu-PSMA-617, for metastatic prostate cancer.

Breast Cancer in Transgender Individuals: More Research Needed
Current literature on breast cancer in transgender and gender-diverse individuals is limited, highlighting a need for more inclusive research and care strategies.

GLP-1 Agonists: Less Weight Loss, Possible Breast Cancer Survival
GLP-1 receptor agonists, while not primarily indicated for oncology, show potential for survival benefits in breast cancer patients.

Metastatic ILC Survival Varies by Mutational Signature
Survival outcomes in metastatic invasive lobular carcinoma (ILC) differ based on specific mutational signatures, impacting treatment stratification.

T-DXd Side Effects in Breast Cancer Warrant Continued Attention
Clinicians must maintain vigilance for adverse events associated with trastuzumab deruxtecan (T-DXd) in breast cancer, particularly interstitial lung disease.

ADA Leader Apologizes for Meeting Removals, Broader Community Concerns
The American Diabetes Association's CEO issued an apology following the removal of members from a meeting, addressing broader community concerns.

Pesticide Exposure Linked to Early-Onset Colorectal Cancer Risk
A common pesticide, permethrin, has been associated with an increased risk of early-onset colorectal cancer, prompting questions about environmental factors in disease etiology.

ACP Issues Guidance on Medications for Obesity, Overweight
The American College of Physicians (ACP) has released new guidance on pharmacologic treatments for obesity and overweight, focusing on efficacy and safety.

Backdoor Roth IRA: A Strategic Necessity for High-Earning Surgeons
High-earning surgeons face income limitations for direct Roth IRA contributions. The backdoor Roth IRA offers a compliant method to access tax-free growth and withdrawals in retirement.

FDA Approves Skinvive for Facial Wrinkles, Including 'Tech Neck' Lines
The FDA has approved Skinvive, an injectable hyaluronic acid gel, for improving skin smoothness and reducing facial wrinkles, including those on the neck.

Metronidazole Reduces Hysterectomy SSIs in Hospital Audit
A hospital audit revealed a significant reduction in surgical site infections (SSIs) following hysterectomy after implementing metronidazole prophylaxis.

Bayer Acquires Perfuse Therapeutics for Ocular Disease Pipeline
Bayer has acquired Perfuse Therapeutics, expanding its ophthalmology pipeline with a focus on diabetic retinopathy and other ocular conditions.

UNAIDS Warns Funding Cuts Threaten HIV/AIDS Progress
UNAIDS reports that reduced funding for HIV/AIDS programmes risks reversing previous gains, potentially increasing new infections and mortality.

ESC Cardio-Oncology 2026: Key Sessions and Anticipated Focus Areas
The ESC Cardio-Oncology 2026 congress will address cardiotoxicity from cancer therapies, focusing on early detection and management strategies.

ADA 2026: Key Diabetes Trials to Watch
The upcoming ADA 2026 conference will feature pivotal trials in diabetes management, focusing on novel GLP-1 receptor agonists and SGLT2 inhibitors.

Disability Insurance: Essential Considerations for Medical Residents
Medical residents face unique challenges in securing disability insurance. Understanding policy types and key features is critical for financial protection.

CMS Adopts Performance-Based Standards for CRC Biomarker Tests
The Centers for Medicare & Medicaid Services (CMS) has implemented new performance-based standards for colorectal cancer (CRC) biomarker tests, despite ongoing questions regarding the clinical utility of some assays.

FDA Clears OTC CGM for Non-Insulin-Using Children Aged 2+
The FDA has cleared an over-the-counter continuous glucose monitor for children aged 2 years and older who do not use insulin.

Purposeful Imbalance: A Strategy for Professional Growth
Achieving professional growth may necessitate a strategic, temporary deviation from conventional work-life balance, termed 'purposeful imbalance.'

Exercise Declined in Patients with Obesity After Starting a GLP-1
Patients with obesity showed reduced physical activity after initiating GLP-1 receptor agonists, according to a recent analysis.

GLP-1 Receptor Agonists Linked to Elevated Hypotension Risk
GLP-1 receptor agonists are associated with an increased incidence of hypotensive events, particularly in patients with pre-existing cardiovascular risk factors.

Classic CAH: New Approaches to Glucocorticoid Dosing
Endocrinology specialists are re-evaluating glucocorticoid dosing strategies for classic congenital adrenal hyperplasia (CAH), focusing on individualised regimens to balance androgen control and minimise adverse effects.

Low Alkaline Phosphatase: Recognizing Clinical Consequences
Low alkaline phosphatase (ALP) is often overlooked, but its clinical consequences, particularly hypophosphatasia, warrant increased diagnostic vigilance.

Afirma Molecular Testing: Unique Situations and New Prognostic Development
Afirma molecular testing aids thyroid nodule management, particularly in indeterminate cytology. New prognostic markers enhance risk stratification.

Severe Hypoglycemia in T1D: Enhancing Patient-Clinician Dialogue
Addressing severe hypoglycemic events in type 1 diabetes requires direct, empathetic clinician-patient conversations to improve management and outcomes.

Endocrinologists' Role in Early Thyroid Eye Disease Recognition
Early recognition of thyroid eye disease (TED) by endocrinologists is critical for optimal patient outcomes, enabling timely intervention.

XLH Adults: Osteomalacia Persists Despite Conventional Therapy
Adults with X-linked hypophosphatemia (XLH) frequently experience persistent osteomalacia, even with conventional phosphate and active vitamin D treatment.

GLP-1 RAs Reduce CV Risk in T2D Via Weight, Glucose Pathways
GLP-1 receptor agonists offer cardiovascular risk reduction in type 2 diabetes through both weight loss and direct glucose-lowering mechanisms.

Desmopressin Dosing Refined for Central Diabetes Insipidus
New insights into desmopressin administration for central diabetes insipidus (CDI) aim to optimise efficacy and minimise hyponatremia risk.

Defining Hyperphagia Treatment Possibilities in Prader-Willi Syndrome
Clinician and caregiver perspectives highlight the complex challenges and unmet needs in managing hyperphagia in Prader-Willi Syndrome.

Hypoparathyroidism Treatment: Patient, Care Partner, HCP Perspectives
New perspectives on hypoparathyroidism treatment from patients, care partners, and HCPs highlight unmet needs and treatment goals.

Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
A novel liver-directed treatment presented at endo 2026 offers a targeted approach for metabolic dysfunction, addressing a significant unmet clinical need.

Lipoprotein(a) Risk: Define, Test Early, Optimise Management
Elevated lipoprotein(a) is an independent, causal risk factor for atherosclerotic cardiovascular disease. Early identification and management are critical.

GLP-1 Agonists and Ischemic Optic Neuropathy: A Review
GLP-1 receptor agonists are widely used for type 2 diabetes and weight management. Recent data suggests a potential association with ischemic optic neuropathy.

FDA Approves First New Sunscreen Active Ingredient in Two Decades
The FDA has approved a new sunscreen active ingredient, bemotrizinol, marking the first such approval in over 20 years. This offers a new option for broad-spectrum UV protection.

Doctors' Regrets: Understanding Their Evolution and Management
Physician regret is a common, evolving experience impacting well-being and practice. Understanding its trajectory is key to mitigation.

Retatrutide Shows 24.2% Weight Reduction in Phase II Trial
A Phase II trial of retatrutide demonstrated substantial weight loss and improvements in cardiometabolic markers in adults with obesity.

Oxygen Titration Protocol Reduces Severe Hyperoxemia in ED
A structured oxygen titration protocol in the emergency department significantly reduced the incidence of severe hyperoxemia, improving patient outcomes.

Racial Bias in Clinical Algorithms Increases Health Disparities
Racial bias embedded in clinical algorithms leads to suboptimal care and increased morbidity for minority patients, necessitating urgent re-evaluation.

Psoriasis Workup Expands Beyond Skin: SDPA 2026 Highlights Systemic Risk
Psoriasis management is evolving, with new guidance emphasizing systemic comorbidities beyond dermatological manifestations.

Belzutifan Plus Pembrolizumab Approved for Adjuvant RCC
The FDA has approved belzutifan plus pembrolizumab for adjuvant renal cell carcinoma, offering a new option for patients at high risk of recurrence.

Virtual Team-Based GI Care Superior to Traditional Care
A virtual team-based care model for gastrointestinal conditions demonstrated superior patient outcomes and reduced healthcare utilisation compared to traditional care.

Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
Chemotherapy-free regimens for pediatric acute promyelocytic leukemia (APL) demonstrate superior efficacy and reduced toxicity compared to traditional chemotherapy.

Medical Residency Competitiveness Rises, Posing Workforce Challenges
The number of medical school graduates seeking residency positions continues to outpace available slots, intensifying competition and impacting physician workforce distribution.

OTC CGM Approved for Paediatric Diabetes Management
Over-the-counter continuous glucose monitoring (CGM) systems are now approved for use in children aged two years and older.

Cellular Reprogramming: Reversing Age-Related Phenotypes in Vitro
Research into cellular reprogramming aims to reverse age-related cellular phenotypes, with early studies demonstrating partial reversal in vitro.

Oral GLP-1 Analogues Show A1c Reduction, Weight Loss at ADA 2026
New data presented at ADA 2026 indicates novel oral GLP-1 receptor agonists significantly lower HbA1c and body weight in type 2 diabetes.

GLP-1 Receptor Agonists: Understanding Oral Manifestations
GLP-1 receptor agonists, used for type 2 diabetes and weight management, are associated with xerostomia and other oral health issues.

GBD 2023: Lower Respiratory Infections Remain Leading Infectious Cause of Death
The Global Burden of Disease Study 2023 confirms lower respiratory infections as the world's leading infectious cause of death.

Radiotherapy and the Heart: Damage, Protection, or Treatment?
Radiotherapy, a cancer treatment, can damage the heart. New research explores hydrogels for protection and the impact of adjuvant therapies.

GBD 2023: LRIs Remain Leading Infectious Cause of Death Globally
The Global Burden of Disease Study 2023 confirms lower respiratory infections (LRIs) as the leading infectious cause of death worldwide.

Comprehensive Care Improves Outcomes for CAYA Cancer Survivors
Comprehensive, multidisciplinary care models are essential for childhood, adolescent, and young adult (CAYA) cancer survivors to mitigate long-term sequelae.

Cardio-Oncology Guidelines: Standardizing CTRCD Management
A consensus statement provides practical guidance for hematology and oncology providers on managing cancer therapy-related cardiac dysfunction (CTRCD).

Cardio-Oncology: Addressing Unmet Needs at ESC Cardio Oncology 2026
Cardio-oncology faces significant unmet needs in patient management, necessitating integrated care pathways and novel therapeutic strategies.

GBD 2023: Cancer and Cardiovascular Disease Mortality Trends Examined
The Global Burden of Disease Study 2023 provides updated cause-specific mortality estimates, offering insights into global health trends.

Cardiotoxicity Monitoring: Evidence-Based Shift from Traditional Methods
ESC Cardio-Oncology 2026 discussions highlight the need to move from traditional cardiotoxicity monitoring to evidence-based strategies.

Cardio-Oncology 2026: Phenotypes, Mechanisms, and Cardioprotection
ESC Cardio Oncology 2026 addressed heart failure and cancer therapy-related cardiac dysfunction, focusing on phenotypes, mechanisms, and cardioprotection.

Cardiovascular Disease and Cancer: A Reciprocal Relationship
Cardiovascular disease and cancer share common risk factors and treatment toxicities, necessitating integrated patient management.

ESC Cardio-Oncology 2026: Bridging Oncology and Cardiology
The 2026 ESC Cardio-Oncology meeting will focus on integrating oncology and cardiology to manage cardiovascular toxicities.

CTRCD Incidence Varies by Cancer Therapy in KP CHEMO Study
New data from the KP CHEMO study quantifies the real-world incidence of cancer therapy-related cardiac dysfunction (CTRCD) across diverse cohorts.

ICI-Related Cardiac Injury: Myocarditis, Coronary, Conduction Disease
Immune checkpoint inhibitors (ICIs) are associated with diverse cardiac toxicities, including myocarditis, coronary artery disease, and conduction abnormalities.

AI-Enabled Cardiocare Pathway Improves Cardio-Oncology Across Ages
An AI-enabled cardio-oncology pathway, Cardiocare, demonstrated improved patient management across age groups at ESC Cardio-Oncology 2026.

Cardio-Oncology 2026: Multidisciplinary Care Expands for Cancer Patients
The 2026 ESC Cardio-Oncology meeting highlights the evolving need for integrated care to manage cardiovascular toxicities in cancer patients.

ESC Cardio-Oncology 2026: Heart Failure Phenotyping in Cancer
ESC Cardio-Oncology 2026 addressed heart failure phenotyping in cancer patients, focusing on imaging and clinical decisions.

ADT and Cardiovascular Risk in Prostate Cancer: ESC Cardio-Oncology 2026
Androgen deprivation therapy (ADT) for prostate cancer increases cardiovascular risk. Clinicians must balance oncological benefit with cardiac safety.

Recognising and Monitoring Cardiac AL Amyloidosis: ESC 2026 Update
Early recognition and consistent monitoring of cardiac involvement in AL amyloidosis are critical for patient prognosis. This update outlines key diagnostic and management strategies.

Fluoropyrimidine Cardiotoxicity: Management Strategies at ESC Cardio Oncology 2026
ESC Cardio Oncology 2026 addressed fluoropyrimidine cardiotoxicity, outlining clinical challenges and emerging management strategies for this common chemotherapy complication.

Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026
Personalised treatment approaches for obesity, moving beyond a 'one-size-fits-all' model, were a key focus at endo 2026.

Hypercortisolism: Emerging Diagnostic and Management Insights
New evidence presented at Endo 2026 refines our understanding of hypercortisolism, impacting diagnostic strategies and therapeutic approaches.

12 Months of Romosozumab Builds Bone Density in Postmenopausal Osteoporosis
A 12-month course of romosozumab significantly increases bone mineral density in postmenopausal women with osteoporosis.

Cushing's Syndrome: Addressing Diagnostic Delays and Treatment Gaps
Cushing's syndrome presents a diagnostic challenge, often leading to significant delays in treatment initiation and suboptimal patient outcomes.

Desiccated Thyroid Extract: Efficacy and Safety in Hypothyroidism
A case-based discussion at endo 2026 reviewed the role of desiccated thyroid extract (DTE) in hypothyroidism management, highlighting patient selection and comparative efficacy.

Korlym® for Cushing's Syndrome: Patient Experience, Side Effects and 2026 Clinical Data
Patient-reported outcomes from Endo 2026 show Korlym® (mifepristone) cuts weight gain, fatigue and mood disturbances in Cushing's syndrome. Covers mechanism of cortisol receptor blockade, side effect profile, and how it compares to relacorilant.

Peer Insights on Once-Daily Weight Management Therapy at endo 2026
Endocrinology specialists discussed the clinical utility of a once-daily treatment for weight management in appropriate adult patients.

Hypothyroidism: Symptom Burden Persists Despite Euthyroidism
Many patients with hypothyroidism report persistent symptoms despite achieving biochemical euthyroidism, highlighting a significant symptom-treatment gap.

Endo 2026: Risk-Based Osteoporosis Management Refines Clinical Practice
Endo 2026 highlighted refined risk-based strategies for osteoporosis care, advocating for tailored interventions beyond universal guidelines to improve patient outcomes.

Steroidogenesis Inhibitor Targets Root Cause of Cushing’s Syndrome
A novel steroidogenesis inhibitor presented at ENDO 2026 offers a targeted approach to endogenous Cushing's syndrome by reducing cortisol overproduction.

Acromegaly Management: Focus on Biochemical Control at ENDO 2026
New insights from ENDO 2026 highlight the persistent challenges in achieving biochemical control for acromegaly patients.

Personalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
EHA 2026 discussions focused on individualized hemophilia care, moving beyond standard prophylaxis to tailored treatment strategies based on patient-specific factors.

Macrophages: Dual Role in Haematological Malignancies Explored
Macrophages exhibit a dual role in haematological malignancies, acting as both tumour suppressors and promoters, influencing disease progression and therapeutic responses.

Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
EHA 2026 will review a quarter-century of molecular hematology, focusing on the integration of genomic data into targeted therapeutic strategies.

Housing Instability Linked to Persistent Diabetic Retinopathy Disparities
A study found that housing instability contributes to persistent disparities in diabetic retinopathy outcomes, even among treatment-adherent individuals.

Brief Brain Stimulation Effective for Depression in Parkinson's Disease
Magnetic seizure therapy (MST) demonstrated non-inferiority to ultra-brief electroconvulsive therapy (ECT) for depression, with fewer cognitive adverse effects.

PMOS: Insulin Resistance Impacts Fertility and Pregnancy Outcomes
Insulin resistance is a key factor in Polycystic Ovary Syndrome (PMOS), affecting reproductive health and increasing pregnancy complications.

Home-Based Stimulation for Bipolar Depression Shows Mixed Efficacy
Home-based transcranial direct current stimulation (tDCS) for bipolar depression yields inconsistent results, with some studies showing modest benefits while others report no significant difference from sham.

AD Biomarkers Linked to Worse Cognition in Midlife Adults
Elevated Alzheimer's disease biomarkers in midlife adults are associated with poorer cognitive performance, indicating preclinical disease progression.

Mesothelioma Survival Challenges Persist in the US
Despite advances in oncology, mesothelioma survival rates in the US remain low, highlighting persistent challenges in early diagnosis and effective treatment.

Diagnostic Accuracy Declines as Clinician Listening Time Shortens
Reduced clinician listening time correlates with decreased diagnostic accuracy and patient satisfaction, impacting care quality and outcomes.

Dementia Linked to Increased Suicidal Behavior Risk
Dementia is associated with an elevated risk for suicidal behavior, particularly when co-occurring with other mental health conditions.

Ultraprocessing Not Inherently Harmful, Context Matters
New perspectives suggest that the health impact of ultraprocessed foods may depend more on nutrient composition than processing level alone.

Psilocybin Effective for TRD in Real-World Trial
Psilocybin-assisted psychotherapy demonstrates clinical efficacy in treatment-resistant depression (TRD) across real-world trials, supporting PAT as a meaningful advance over standard care.

Hydrofluoric Acid Burns: Missed Diagnoses Lead to Delayed Treatment
Hydrofluoric acid burns are frequently misdiagnosed due to non-specific initial symptoms, delaying critical calcium gluconate therapy and increasing morbidity.

The Escalation Debate
Should clinicians start with high-efficacy therapy or escalate from low-efficacy agents? TREAT-MS and DELIVER-MS have generated data that reframes the question, and the answer is more nuanced than either camp admits.

Targeting Tau Inflammation And Alzheimer's Metabolism
Amyloid clearance is only one part of the Alzheimer's story. Why tau remains the closer correlate of cognitive decline, what the TREM2 biology tells us about microglia, what the GLP-1 signal means, and how platform trials are moving toward multi-target combination therapy.

The Amyloid Hypothesis, Finally Validated?
After two decades of high-profile failures, lecanemab and donanemab have produced the first positive phase 3 trials in Alzheimer's disease. We examine the CLARITY-AD and TRAILBLAZER-ALZ 2 data, the clinical meaningfulness debate, and what the approvals actually mean at the bedside.

Why New Alzheimer's Drugs Make Brains Bleed?
ARIA (amyloid-related imaging abnormalities) affects up to 24% of patients on anti-amyloid therapy. APOE4 genotyping, MRI monitoring protocols, severity-graded management, and the anticoagulation dilemma: a practical guide to navigating the risk.

Preventing 45 Percent Of Dementia Cases
The Lancet Commission 2024 estimates 45% of dementia is preventable. SPRINT-MIND showed 19% MCI reduction from intensive blood pressure control. FINGER showed 25% better cognitive scores with multi-domain lifestyle intervention. ACHIEVE showed 48% slowing in high-risk patients with hearing aids. The evidence is here and we walk through it.

Dexamethasone Offers No Benefit in Headache After Occipital Nerve Block
Adding dexamethasone to greater occipital nerve blocks does not improve headache intensity or duration, according to recent clinical evidence.

Exosomes Emerge as Cell-Free Option in Regenerative Medicine
Exosomes, nanoscale vesicles, are gaining attention in regenerative medicine as a cell-free therapeutic alternative, offering potential benefits over traditional cell therapies.

Psoriasis Patients Report Chronic Intense Pain, Multiple Pain Sites
Psoriasis is associated with chronic intense pain and a higher prevalence of multiple pain sites, impacting patient quality of life.

Waist Size, Muscle Mass Predict CKD Prognosis, Mortality Risk
Abdominal obesity and sarcopenia are independent predictors of adverse outcomes in chronic kidney disease (CKD), influencing mortality and disease progression.

ACOG Simplifies Maternal Immunisation Schedule for GPs
ACOG has streamlined its maternal immunisation schedule, consolidating recommendations to improve adherence and reduce vaccine-preventable diseases in mothers and neonates.

C. difficile Hospital Deaths Rose During COVID-19 Pandemic
Hospital deaths attributed to Clostridioides difficile infection increased during the COVID-19 pandemic, indicating a critical need for enhanced infection control.

Acupuncture Reduces Insulin Needs in Type 2 Diabetes
Acupuncture, an ancient Chinese therapy, has demonstrated efficacy in reducing insulin requirements for patients with type 2 diabetes.

ctDNA Predicts Relapse in Early Cancer, but Clinical Action Remains Unclear
Circulating tumour DNA (ctDNA) detection post-surgery predicts relapse in early-stage cancer, but evidence for adjuvant therapy escalation based solely on ctDNA is lacking.

Orforglipron Phase 3 Trials Show Efficacy in T2D Management
Oral GLP-1 receptor agonist orforglipron demonstrates significant reductions in HbA1c and body weight in Phase 3 trials for type 2 diabetes.

Federal Research Supports Lower Drinking Limits for Health
New federal research indicates that current alcohol consumption guidelines may be insufficient to mitigate health risks, advocating for tighter limits.

Patient Debt Complicates Doctor-Patient Relationships, Care Decisions
Growing patient debt is forcing difficult conversations in clinical settings, impacting treatment adherence and patient trust.

ITP Management: Bridging Clinician and Patient Perspectives
Chronic immune thrombocytopenia (ITP) management: a clinical review aligning physician treatment strategies with patient quality-of-life priorities, long-term outcomes, and disease burden in chronic ITP.

CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
Strategies for initiating and sequencing targeted therapy in CLL must align with patient priorities and evidence for long-term benefit.

Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026
EHA 2026 discussions on cytopenic myelofibrosis focused on risk stratification and treatment selection, emphasizing ruxolitinib and pacritinib.

CAR T: Speed and Reliability Critical for Patient Outcomes
CAR T-cell therapy for glioblastoma multiforme (GBM) requires rapid, reliable delivery to improve patient outcomes, addressing current translational limitations.

DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option
Current bispecific antibody options in relapsed/refractory DLBCL — including epcoritamab and glofitamab as T-cell engager therapies — reviewed for efficacy, safety, and sequencing after CAR-T or prior lines of therapy.

CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026
EHA 2026 discussions highlight evolving CAR T-cell therapy guidelines for lymphoma and multiple myeloma, focusing on patient selection and sequencing.

Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review
Review of EHA 2026 data on frontline treatment for lower-risk myelodysplastic syndromes (LR-MDS), focusing on erythroid response and transfusion independence.

CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations
First-line venetoclax combinations versus BTK inhibitors in chronic lymphocytic leukaemia (CLL): EHA 2026 evidence on venetoclax-obinutuzumab, ibrutinib, and acalabrutinib efficacy, safety, and patient selection criteria.

Novel Approaches Address Multiple Myeloma Resistance at EHA 2026
Multiple myeloma treatment faces challenges with resistance. New strategies presented at EHA 2026 offer insights into overcoming these hurdles.

CD20-Targeted Therapies Remain Central to NHL Management
CD20-directed agents continue to underpin non-Hodgkin lymphoma treatment, with ongoing refinements in antibody-drug conjugates and bispecifics.

Infection Prevention Critical in Hematological Malignancies
Patients with hematological malignancies face a high risk of infection, necessitating proactive prevention strategies to improve outcomes.

NDMM Treatment Optimisation: Communication Key to Individualisation
Optimising treatment for newly-diagnosed multiple myeloma (NDMM) requires patient-centred communication to individualise therapy and improve outcomes.

FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies
EHA 2026 reviewed current strategies for FLT3-mutated acute myeloid leukaemia, focusing on targeted therapies and their impact on patient outcomes.

BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies
The management of chronic lymphocytic leukemia (CLL) with BTK inhibitors is evolving, necessitating careful consideration of treatment sequencing and resistance mechanisms.

Evolving Infection Prevention in HSCT and Cellular Therapies
Infection prevention in allogeneic HSCT and cellular therapies faces challenges from evolving pathogens and treatment modalities. New strategies are emerging.

Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma
Bispecific antibodies offer a new treatment avenue for relapsed/refractory multiple myeloma, demonstrating high response rates in heavily pretreated patients.

Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
New data presented at EHA 2026 highlight emerging therapeutic strategies for chronic lymphocytic leukemia (CLL) patients progressing after covalent BTK inhibitor (cBTKi) therapy, demonstrating improved progression-free survival and response rates.

Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma
Bispecific antibodies offer new options for relapsed/refractory follicular lymphoma, particularly after two prior lines of therapy.

Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera
New insights from EHA 2026 clarify the role of iron status in erythrocytosis and symptom burden in polycythemia vera patients.

CML Survivorship: Beyond Survival to Quality of Life
Chronic myeloid leukemia (CML) management has shifted from survival to quality of life, focusing on treatment-free remission and symptom burden.

Immune Drivers in Autoimmune Cytopenias Inform Patient Care
Understanding immune drivers in autoimmune cytopenias, discussed at EHA 2026, offers insights into targeted therapies and improved patient management.

CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma
CAR T-cell therapy demonstrates durable responses in relapsed/refractory large B-cell lymphoma, addressing a critical unmet need.

CLL First-Line Therapy: Case-Based Insights from EHA 2026
EHA 2026 session explores first-line chronic lymphocytic leukemia (CLL) therapy through interactive case studies, addressing evolving treatment paradigms.

Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026
EHA 2026 discussions on multiple myeloma focused on integrating novel therapies into established treatment algorithms, addressing challenges in patient selection and sequence optimization.

DLBCL Treatment: Emerging Targeted Therapies at EHA 2026
An expert roundtable at EHA 2026 discussed new and emerging targeted therapies for diffuse large B-cell lymphoma (DLBCL).

Caplacizumab Improves iTTP Outcomes in Real-World Settings
Real-world data presented at EHA 2026 confirm caplacizumab's efficacy in immune-mediated thrombotic thrombocytopenic purpura (iTTP), reducing refractory disease and mortality.

Real-World Data Confirms Proximal Complement Inhibition in PNH
Real-world evidence presented at EHA 2026 validates the efficacy and safety of proximal complement inhibition in paroxysmal nocturnal hemoglobinuria (PNH).

BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma
BCMA-directed therapies are emerging as a critical treatment option for relapsed/refractory multiple myeloma, addressing a significant unmet need.

CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026
CAR T-cell therapy for diffuse large B-cell lymphoma (DLBCL) presents a complex treatment landscape. EHA 2026 data focuses on refining patient selection and management strategies to improve efficacy and safety.

CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden
Subcutaneous CD38 monoclonal antibody administration in quad therapy for multiple myeloma significantly reduces treatment burden and improves patient experience.

Novel Approaches in R/R MM: Expert Perspectives from EHA 2026
Emerging data from EHA 2026 highlight advancements in relapsed/refractory multiple myeloma, focusing on CAR T-cell therapies and bispecific antibodies.

DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies
EHA 2026 explored optimal treatment sequencing for diffuse large B-cell lymphoma (DLBCL) with current therapeutic options.

NDMM Treatment Advances: Quadruplet Regimens Show Efficacy
Newly diagnosed multiple myeloma (NDMM) treatment is evolving, with quadruplet regimens demonstrating improved depth of response and progression-free survival.

AML Treatment Strategies: Optimising Outcomes in a Complex Disease
Acute myeloid leukemia (AML) presents significant treatment challenges. This review explores current strategies to improve patient outcomes.

Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes
Interactive case-based journey at EHA 2026 explores optimal integration of bispecific antibodies in follicular lymphoma management.

MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies
Optimising first-line treatment for haematologic malignancies requires balancing continuous and fixed-duration therapies, with Measurable Residual Disease (MRD) status emerging as a critical determinant.

Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies
Bispecific antibodies offer a new therapeutic avenue for relapsed/refractory non-Hodgkin lymphoma and multiple myeloma, demonstrating encouraging response rates.

CLL: EHA 2026 to Address Unmet Needs in Treatment Selection
EHA 2026 will focus on critical questions in chronic lymphocytic leukemia (CLL) care, particularly treatment selection and resistance mechanisms.

Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives
EHA 2026 highlighted real-world strategies for optimising transplant outcomes in haemoglobinopathies, focusing on conditioning and graft sources.

JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026
New data from EHA 2026 indicate that combination therapies involving JAK inhibitors may improve outcomes for myelofibrosis patients.

DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy
EHA 2026 discussions highlight persistent challenges in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) management, focusing on optimal sequencing and novel agent integration.

AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
EHA 2026 data challenges current intensive therapy strategies for AML with myelodysplasia-related changes and therapy-related AML.

Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis
New data from the Summit and Apex trials demonstrate avapritinib's efficacy in systemic mastocytosis, offering a targeted treatment option.

FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant
FLT3 inhibitors are increasingly critical in AML management, improving transplant eligibility and post-remission outcomes, with new combination data emerging.

IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months
Combination therapy with ivosidenib and azacitidine significantly extends overall survival in newly diagnosed IDH1-mutant AML patients.

AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
The EHA 2026 session addresses the immediate need for hematologists to integrate AI tools ethically and practically into clinical workflows.

BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026
EHA 2026 data indicates BCMA bispecific antibodies can be integrated into community practice for relapsed/refractory multiple myeloma.

Inflammation Drives Sickle Cell Disease Pathophysiology
Sickle cell disease (SCD) is characterised by chronic inflammation, contributing to vaso-occlusive crises and organ damage. Targeting inflammatory pathways may offer therapeutic avenues.

Strategies Emerge to Mitigate Post-GLP-1 Weight Regain
Weight regain following cessation of GLP-1 receptor agonist therapy presents a clinical challenge; emerging strategies focus on sustained pharmacological intervention and lifestyle modification.

PROTEUS Trial: Neoadjuvant Apalutamide Plus ADT in High-Risk Prostate Cancer
The PROTEUS trial investigated neoadjuvant apalutamide plus ADT for high-risk localised prostate cancer, showing improved pathologic complete response rates.

Alcohol's Role in Healthy Lifestyle: A Reassessment
Recent GBD data and related studies prompt a re-evaluation of alcohol's place in a healthy lifestyle, particularly concerning mental health and longevity.

Zurich Heart Surgery Scandal: Device Safety Alert Issued
A safety alert has been issued regarding cardiac devices used in Zurich, prompting concerns about patient outcomes and regulatory oversight.

Normal Flatus Frequency: Up to 25 Episodes Daily Considered Typical
Understanding normal flatus frequency is essential for distinguishing physiological gas from symptoms of gastrointestinal pathology. Up to 25 episodes per day is typical.

Semaglutide Not Linked to Increased AMD Risk in New Analysis
A recent study found no statistically significant association between semaglutide use and the incidence of age-related macular degeneration (AMD).

Semaglutide Accepted in Scotland for CV Risk Reduction in T2D
Semaglutide has been accepted in Scotland for reducing cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease.

Doppler Measures Identify Brain Injury Risk in Fetal Growth Restriction
Doppler ultrasound assessment of fetal circulation identifies fetuses with growth restriction at increased risk of brain injury.

CGRP Monoclonal Antibodies for Migraine Linked to Fracture Risk
New data indicate CGRP monoclonal antibodies, used for migraine prevention, may be associated with an increased risk of bone fractures. Clinicians should consider this risk.

AI Enhances Oxygen Therapy Titration, Reduces Hypoxia Duration
Artificial intelligence algorithms are demonstrating efficacy in automating oxygen therapy titration, potentially reducing episodes of hypoxia and hyperoxia.

Serum Potassium Concentrations Shape Heart Failure Risk
Optimal serum potassium concentrations in heart failure (HF) are unclear, with new data clarifying the safe range for HFrEF and HFpEF.

PCOS Linked to Increased All-Cause Mortality Risk in Women
Polycystic Ovary Syndrome (PCOS) is associated with a significantly elevated risk of all-cause mortality, particularly from cardiovascular disease and diabetes.

Novel Tool Predicts Difficult-To-Treat Depression Risk at APA 2026
A new predictive tool identifies patients at high risk for difficult-to-treat depression, potentially guiding earlier, more aggressive interventions.

FDA's Hormone Therapy Decision: Implications for Aging Skin
The FDA's recent decision regarding hormone therapy for menopausal symptoms has implications for skin aging, a common patient concern.

BMI Does Not Increase Complication Risk After Reverse Total Shoulder Arthroplasty
A new study indicates that body mass index (BMI) does not elevate the risk of complications following reverse total shoulder arthroplasty (rTSA).

Europe's Medical Loophole Allows Banned Doctors to Practice
A regulatory gap in Europe permits doctors struck off medical registers in one country to practice in another, posing patient safety risks.

CAR-T Therapy Versus Bispecific Antibodies
The next phase of CAR-T addresses its biggest limitations: off-the-shelf allogeneic products, in vivo gene delivery, and bispecific antibodies that redirect T cells without any gene engineering. Sarah Mitchell and James Carter explore where the technology is going - and what blood cancer management looks like by 2030.

Small Molecules VS CAR-T In CLL
By the time CAR-T arrived in CLL, the disease had already been transformed by BTK inhibitors and venetoclax. TRANSCEND CLL 004 showed 18% CR in BTKi/venetoclax-refractory disease. Sarah Mitchell and James Carter explore why CLL is harder for CAR-T, where it still has a role - especially in Richter's transformation - and why timing of T cell collection matters.

Moving CAR-T To Earlier Myeloma Lines
Ciltacabtagene autoleucel achieved a 97% overall response rate and 67% complete response in triple-class refractory multiple myeloma - numbers not thought achievable a decade ago. CARTITUDE-4 has now moved it to the second line. Sarah Mitchell and James Carter cover the BCMA story, the new targets, and the resistance mechanisms driving the next generation.

CAR-T Masterstroke Or Biological Chaos?
In 2012, a 6-year-old with relapsed ALL became the first child successfully treated with CAR-T cell therapy. That case launched a revolution. Sarah Mitchell and James Carter explain how chimeric antigen receptor T cells are engineered, why CD19 was the first target, and why CRS and ICANS are the price of their potency.

Why Cheaper Humira Alternatives Face Resistance
Humira (adalimumab) biosimilar alternatives have cut NHS spend by over 50% while expanding treatment access. Evidence from NOR-SWITCH confirms switching is safe, yet resistance persists, driven by the nocebo effect and physician inertia.

Stopping Spinal Fusion Or Protecting The Gut?
PsA is not RA with skin, and axSpA is not RA in the spine. The biologic hierarchy shifts significantly across the spondyloarthropathy spectrum - IL-17 and IL-23 inhibitors dominate, anti-TNF has uveitis caveats, and IBD comorbidity changes everything. Sarah Mitchell and James Carter explain how EULAR 2026 data shapes the choices.

Chasing Absolute Zero In Rheumatoid Arthritis
Treat-to-target transformed RA outcomes - not through new drugs but through rigorous measurement and escalation discipline. Sarah Mitchell and James Carter cover the evidence base, the disease activity tools, the window of opportunity in early RA, and when tapering biologics in sustained remission is safe.

The ORAL Surveillance JAK Inhibitor Controversy
ORAL Surveillance showed tofacitinib carried higher cardiovascular and malignancy risk than anti-TNF in high-risk RA patients - triggering a class-wide boxed warning. But was the signal overgeneralised? Sarah Mitchell and James Carter unpack the data, the controversy, and how to make the JAKi-vs-biologic decision in 2026.

Managing Acute Heart Failure And Cardiogenic Shock
Acute decompensated heart failure drives over one million hospital admissions annually. 30-day readmission rates are 25%. When the heart cannot compensate, the tools change entirely - IV diuretics, inotropes, mechanical circulatory support. Sarah Mitchell and James Carter cover ADHF management, cardiogenic shock, and how to prevent the revolving door.

Semaglutide For Obese Heart Failure Patients
More than 80% of HFpEF patients are overweight or obese. STEP-HFpEF showed semaglutide 2.4mg improved symptoms by 16 points on the KCCQ and reduced weight by 13.3% - now a Class IIa ESC recommendation. Sarah Mitchell and James Carter explore why treating the metabolic environment is the new paradigm for HFpEF.

Diabetes Drugs For Stiff Heart Failure
Heart failure with preserved ejection fraction accounts for more than half of all HF diagnoses. For two decades every major drug trial failed. Then SGLT2 inhibitors changed everything - twice. Sarah Mitchell and James Carter explain why HFpEF was so hard, and what finally worked.

How Four Drugs Beat Heart Failure
Four drug classes (ARNi, beta-blocker, MRA, SGLT2 inhibitor) have together produced a 73% reduction in cardiovascular death and hospitalisation versus placebo in HFrEF. Sarah Mitchell and James Carter unpack why each drug works, what the landmark trials showed, and why clinical inertia is still the biggest barrier to optimal care.

B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
New research presented at EULAR 2026 explores upstream B-cell targeting to address primary Sjögren disease pathology, focusing on early intervention.

XLH Management: Rheumatology Must Adapt at EULAR 2026
Current rheumatology approaches for rare bone diseases like X-linked hypophosphatemia (XLH) require re-evaluation. EULAR 2026 presents an opportunity to integrate multidisciplinary care models.

EGPA: Early Recognition & Targeted Intervention Improve Outcomes
Eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic challenges; timely intervention is critical for improved patient outcomes.

RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
Rheumatoid arthritis (RA) significantly increases fracture risk beyond traditional factors. EULAR 2026 data underscores the need for early bone health assessment.

Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
Salivary galectin-9 levels are elevated in primary Sjögren's disease but do not correlate with disease activity or symptoms.

TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026
New insights into systemic lupus erythematosus (SLE) pathogenesis highlight the role of TLR7/8, with emerging therapeutic strategies.

Early Intervention in SLE/LN Reduces Long-Term Damage
Acting early in systemic lupus erythematosus (SLE) and lupus nephritis (LN) is critical for preventing irreversible organ damage and improving patient outcomes.

Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis
EULAR 2026 addressed evolving concepts in systemic sclerosis, focusing on refined diagnostic criteria and prognostic indicators for earlier intervention.

CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management
Targeting CD19+ B-cells offers a corticosteroid-sparing strategy for IgG4-Related Disease, addressing relapse rates and long-term toxicity.

Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026
A EULAR 2026 session addressed the diagnostic delay in axial spondyloarthritis, highlighting the need for improved GP recognition and referral pathways.

Multidisciplinary Care Improves Spondyloarthritis Outcomes
A multidisciplinary approach to spondyloarthritis, addressing both articular and extra-musculoskeletal manifestations, improves patient outcomes.

Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Effective doctor-patient communication, focusing on patient self-blame, significantly increases treatment acceptance rates in cancer patients.

Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
New data presented at ASCO 2026 indicate that tafasitamab combined with R-CHOP improves outcomes for newly diagnosed DLBCL patients.

Traffic Pollution Linked to Distinct Chronic Rhinosinusitis Phenotypes
Exposure to traffic-related air pollution is associated with specific inflammatory patterns in chronic rhinosinusitis, indicating environmental triggers.

Reassuring Data for High-Efficacy MS Meds in Pregnancy
New data provide reassurance regarding the use of high-efficacy multiple sclerosis therapies during pregnancy, addressing a significant clinical dilemma.

Bowel Hygiene: A Neglected Aspect of Patient Care
Addressing bowel hygiene is essential for patient well-being, impacting conditions from constipation to chronic disease management.

Guselkumab Label Adds Psoriatic Arthritis Structural Damage Inhibition
Guselkumab (Tremfya) has received an updated label to include inhibition of structural damage progression in psoriatic arthritis.

Tile Radiation for Large Brain Mets: A New Approach at ASCO 2026
Tile-based radiation therapy for large brain metastases was presented at ASCO 2026, offering a novel strategy for dose escalation.

More Breast Cancer Patients Can Skip Axillary Dissection
New data presented at ASCO 2026 indicates an expanded cohort of breast cancer patients can safely omit axillary lymph node dissection.

2026 Dyslipidemia Guideline: Utility in Family Medicine Assessed
A new assessment tool, G-TRUST, evaluates the relevance and trustworthiness of cardiovascular risk guidelines, including statin recommendations.

Federal Vaping Policy Shifts, Clinicians Front Line in Youth Prevention
Recent federal policy adjustments have repositioned clinicians as primary agents in preventing youth vaping. This necessitates updated screening and intervention strategies.

Alcohol and Sugar: A Dual Metabolic Challenge for Patients
Patients consuming alcohol and high-sugar diets face a compounded metabolic risk, impacting liver function and glucose regulation. Clinicians must address both factors.

SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026
New insights into systemic lupus erythematosus (SLE) pathophysiology presented at EULAR 2026 highlight pathways for targeted therapies and precision medicine.

EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE
EULAR 2026 guidelines for polymyalgia rheumatica (PMR) integrate real-world evidence (RWE), refining diagnostic and treatment algorithms.

Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention
EULAR 2026 will address the critical need for early, targeted intervention in psoriatic arthritis and axial spondyloarthritis to improve patient outcomes.

VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
EULAR 2026 discussions highlight the need for integrated, multidisciplinary approaches to VEXAS syndrome, focusing on early diagnosis and targeted management.

ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
New strategies in ANCA-associated vasculitis (GPA/MPA) focus on achieving sustained remission and preventing relapse with targeted therapies.

CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026
CAR T cell therapy demonstrates promising efficacy in refractory autoimmune diseases, offering a potential new therapeutic avenue for severe cases.

Lupus Management: Progress and Persistent Challenges at EULAR 2026
Systemic lupus erythematosus (SLE) remains a complex autoimmune disease with significant unmet needs despite therapeutic advancements. EULAR 2026 will review current progress and future directions.

Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases
EULAR 2026 highlights the role of autoantibodies in autoimmune rheumatic diseases, offering insights into early diagnosis and targeted therapies.

SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026
EULAR 2026 highlights a critical disconnect in spondyloarthritis (SpA) remission, where patient-reported symptom resolution often belies persistent subclinical inflammation.

Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms
New insights at EULAR 2026 highlight the need to address objective disease activity in Sjögren’s, moving beyond symptomatic management.

EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line
EULAR 2026 reaffirms methotrexate's central role in first-line rheumatoid arthritis therapy, with new data on optimal dosing and combination strategies.

Obesity Management Improves Psoriatic Disease Outcomes
Addressing obesity in psoriatic disease patients improves dermatological and musculoskeletal outcomes, highlighting the need for integrated care strategies.

CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset
CAR T cell therapy is emerging as a potential immune reset strategy for severe systemic lupus erythematosus and systemic sclerosis, offering a new therapeutic avenue.

Multidisciplinary Approach Improves Autoimmune ILD Management
A collaborative model involving rheumatology, radiology, and pulmonology is essential for effective autoimmune interstitial lung disease (ILD) care.

Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus
EULAR 2026 highlights the critical role of rapid disease control in systemic lupus erythematosus (SLE) to mitigate irreversible organ damage.

RA Treatment Optimisation: Applying Two Decades of Progress
EULAR 2026 highlights the evolution of rheumatoid arthritis management, emphasising early, aggressive intervention and treat-to-target strategies.

Belantamab Mafodotin's Evolving Role in RRMM: EHA 2026 Insights
Belantamab mafodotin's position in relapsed/refractory multiple myeloma treatment continues to evolve, with new data presented at EHA 2026 refining its application.

Infection Prevention Critical in Hematological Malignancies
Infections remain a leading cause of morbidity and mortality in hematological malignancy patients. Prophylactic strategies are essential.

Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Allogeneic cell therapy is a treatment option for Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility
EHA 2026 data indicates that functional fitness assessments, rather than chronological age, should guide intensive chemotherapy eligibility in AML.

Rare Conditions: EHA 2026 Highlights Diagnostic Challenges
EHA 2026 session 'The Sherlock Holmes Approach' addressed diagnostic delays in rare haematological conditions, emphasizing systematic clinical reasoning.

Amyloid Therapies Show Limited Cognitive Benefit in Alzheimer's
Amyloid-beta targeting therapies for Alzheimer's disease demonstrate modest effects on cognitive decline, with clinical significance remaining uncertain.

EHA 2026: Anticipating Advances in Haematological Malignancies
EHA 2026 is expected to feature updates on novel therapies for haematological malignancies, focusing on targeted agents and cellular therapies.

EULAR 2026: Key Rheumatology Trials to Watch
Anticipated trials at EULAR 2026 will address unmet needs in psoriatic arthritis and systemic lupus erythematosus, focusing on novel therapeutic targets.

Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions
Early identification of interstitial lung disease (ILD) in systemic autoimmune rheumatic diseases (SARD) and systemic sclerosis (SSc) is critical.

Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026
Achieving early disease control in systemic lupus erythematosus (SLE) is critical for preventing organ damage. Targeting the interferon (IFN) pathway offers a precise therapeutic strategy.

Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk
Treat-to-target strategies in Systemic Lupus Erythematosus (SLE) aim for optimal disease control but introduce patient burden and potential risks.

Immuno-Fibrotic Crosstalk: A New Target in Rheumatology
EULAR 2026 will address the complex interplay between immune and fibrotic pathways in rheumatic diseases, offering new therapeutic avenues.

EULAR 2026: Psoriatic Disease Spectrum Highlights
EULAR 2026 presentations address the broad clinical manifestations of psoriatic disease, emphasizing early diagnosis and tailored management across its diverse phenotypes.

Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis
EULAR 2026 highlights the imperative of early diagnosis and intervention in inflammatory joint diseases and osteoporosis to prevent irreversible damage.

EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden
New insights from EULAR 2026 highlight the critical role of early diagnosis and optimised management strategies in reducing the disease burden of axial spondyloarthritis (axSpA).

RA Care: Navigating Treatment Choices at EULAR 2026
Rheumatoid arthritis management requires precise treatment selection. EULAR 2026 highlights the ongoing challenge of optimising therapy.

HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
Sevabertinib, a novel tyrosine kinase inhibitor, demonstrates efficacy in advanced solid tumours, offering a new therapeutic option.

Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
Molecular residual disease (MRD) detection is critical for oncology. The Oncodetect® test demonstrates analytical and clinical evidence.

TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
A phase II trial demonstrates improved overall survival with TACE combined with camrelizumab and rivoceranib for unresectable HCC.

New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD
A novel 2L+ combination therapy demonstrates improved outcomes for adults with relapsed/refractory multiple myeloma (RRMM) after prior proteasome inhibitor (PI) and immunomodulatory agent (IMiD) exposure.

Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL
A novel fixed-duration combination therapy with a BCL-2 inhibitor as backbone provides treatment-free intervals for patients with first-line CLL.

Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
A new subcutaneous immunotherapy formulation provides a convenient alternative for patients, potentially reducing administration time and healthcare resource utilization.

Bispecific Antibodies Efficacious in Multiple Myeloma with Renal Impairment
A systematic review confirms bispecific antibodies show comparable efficacy and manageable safety in relapsed/refractory multiple myeloma patients with renal impairment.

MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
Multi-cancer early detection (MCED) tests offer a potential strategy for earlier cancer diagnosis, particularly for cancers lacking standard screening.

MLVs: Dual Role in Brain Metastases Offers Therapeutic Targets
Meningeal lymphatic vessels (MLVs) exhibit a dual role in brain metastases, initially promoting anti-tumor immunity but later facilitating dissemination.

PEAK Study Shows Novel Agent Improves PFS in Advanced GIST
The Phase 3 PEAK study demonstrated improved progression-free survival with a novel therapeutic agent in advanced gastrointestinal stromal tumors (GIST).

Myriad's Precise MRD™ Test Shows Ultra-Sensitive Detection at ASCO 2026
Myriad's Precise MRD™ test offers ultra-sensitive molecular residual disease detection, potentially guiding adjuvant therapy decisions.

Outsmarting Shape-Shifting Lung Cancer Resistance
Resistance to EGFR inhibitors is almost inevitable, but the mechanisms are predictable and increasingly targetable. From T790M acquired resistance to osimertinib, through FLAURA2 combination strategies, Sarah Mitchell and James Carter explain how the field is staying one step ahead of lung cancer.

Targeted ADCs For Advanced Lung Cancer
Antibody-drug conjugates have redefined what targeted therapy means in lung cancer. Trastuzumab deruxtecan in HER2-mutant NSCLC and datopotamab deruxtecan in TROP2-expressing disease are producing responses that older chemotherapy could not approach. Sarah Mitchell and James Carter cover the ADC revolution.

How Immunotherapy Unmasks Invisible Lung Cancer
PD-L1 expression is the gatekeeper to first-line immunotherapy in NSCLC, but the biology of why some tumours respond and others do not remains one of oncology's central questions. Sarah Mitchell and James Carter examine the landmark trials that established checkpoint inhibitors as standard of care.

Hacking the Lung Cancer Genetic Code
EGFR, ALK, ROS1, KRAS: lung cancer has more targetable mutations than any other solid tumour. Sarah Mitchell and James Carter unpack how genomic profiling transformed NSCLC from a single disease into a collection of precision targets, and what each mutation means for treatment choice.

ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data
The ASCO 2026 June 1st program focused on advancements in immunotherapy, particularly for solid tumours, with new data presented on combination strategies.

ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies
The ASCO 2026 May 31st program highlighted advancements in novel immunotherapies, particularly in solid tumours and haematological malignancies.

ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors
The ASCO 2026 May 30th program focused on immunotherapy in solid tumors, presenting data on novel combinations and biomarker-driven strategies.

HER2-Expressing Breast Cancer: Advancements in Targeted Therapies
New therapeutic strategies for HER2-expressing breast cancer presented at ASCO 2026 demonstrate improved outcomes across disease stages.

AI Foundation Models Enhance Diagnostic Insights in Oncology
AI foundation models presented at ASCO 2026 demonstrate potential to improve diagnostic precision and challenge existing oncology paradigms.

Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities
ASCO 2026 will address cancer elimination, focusing on prevention, early detection, and treatment advancements. Current evidence suggests a multi-faceted approach is necessary.

TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations
TRUQAP with fulvestrant offers a second-line treatment for HR+/HER2- advanced or metastatic breast cancer with specific PI3K-AKT pathway alterations.

Inluriyo™ and Verzenio® Presentations at ASCO 2026
Upcoming ASCO 2026 presentations will detail imlunestrant and abemaciclib, offering new data on endocrine therapy for breast cancer.

CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Emerging CELMoD research at ASCO 2026 highlights novel therapeutic strategies for relapsed/refractory multiple myeloma, addressing evolving patient needs.

ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies
The ASCO 2026 May 29th program focused on advancements in targeted therapies and immunotherapies across various cancer types, presenting data on efficacy and safety.

Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety
Radiopharmaceutical therapy (RPT) offers targeted cancer treatment, but challenges in efficacy, patient access, and risk mitigation persist.

Symptom Science Integration Improves Cancer Outcomes at ASCO 2026
Translating symptom science into clinical practice demonstrably improves patient outcomes in oncology, as highlighted at ASCO 2026.

Novel Biomarkers Improve Pediatric Solid Tumor Detection
New biomarkers enhance early detection and risk stratification in pediatric solid tumors, offering potential for more targeted therapeutic strategies.

Immunotherapy and Targeted Therapy: New Data from ASCO 2026
New research from ASCO 2026 explores combination strategies for advanced cancers and a machine learning approach to immunotherapy target discovery.

ICI Dissemination Challenges Highlighted at ASCO 2026
Global disparities in immune checkpoint inhibitor access and toxicity management were a key focus at ASCO 2026, revealing persistent implementation gaps.

Cancer Care Disparities Highlighted in Crisis, Displaced Populations
ASCO 2026 discussions underscore significant challenges in delivering equitable cancer care during crises and to immigrant and displaced populations.
Neurological research: More accurate brain models mean better patient insights
New methodologies improve the identification of complex dynamic states, such as chimera states and traveling waves, in simulated neural networks.

The real reason for preeclampsia's placental injury: Mitochondria
A systematic review highlights the under-examined roles of NLRP1 and mitochondrial signals in preeclampsia pathogenesis.

Genome Sequencing: Understanding DNA Composition and Function
Scientists determine the precise order of nucleotides in an organism's DNA, revealing genetic information and potential disease predispositions.

Super Agers Maintain Cognitive Function Through Specific Brain Networks
Research into 'Super Agers' reveals distinct neurobiological profiles that preserve cognitive function into advanced age, offering insights into healthy aging.

The GLP-1 Muscle Loss Dilemma
GLP-1 receptor agonists drive significant lean mass loss alongside fat loss, a concern that may undermine long-term metabolic health and physical function. Sarah Mitchell and Matt Aldrich examine the muscle loss evidence, the role of resistance training, and emerging strategies to preserve lean tissue during weight loss.

The Velvet Rope Of Weight Loss Drugs
Semaglutide and tirzepatide produce results that obesity medicine has never seen before, but demand vastly outstrips supply, cost remains prohibitive for many, and prescribing criteria vary widely between health systems. Sarah Mitchell and James Carter examine who is getting GLP-1 therapy and why equity matters.

GLP-1 Drugs Protect Hearts And Kidneys
SELECT, LEADER, SUSTAIN-6, STEP-HFpEF: GLP-1 receptor agonists have accumulated cardiovascular and renal outcomes data that most drug classes can only aspire to. Sarah Mitchell and James Carter examine why these drugs are now being prescribed by cardiologists and nephrologists as well as endocrinologists.

Rewiring The Brain To Silence Food Noise
GLP-1 receptor agonists do far more than lower blood glucose: they reshape the brain's reward response to food, suppress appetite at the hypothalamic level, and slow gastric emptying. Sarah Mitchell and James Carter explain the neuroscience behind the most transformative class of drugs in a generation.

Is It Safe To Switch Biosimilars?
The NOR-SWITCH trial established that switching from reference infliximab to a biosimilar is safe. Multiple subsequent studies have confirmed this across adalimumab and other biologics. Sarah Mitchell and James Carter examine the switching evidence, the nocebo effect, and how the biosimilar dividend is reshaping access to care.

Why Half Of Psoriasis Patients Quit
Up to half of psoriasis patients discontinue their treatment within a year. The reasons are complex: side effect fear, injection fatigue, visible improvement masking ongoing disease. The solutions require as much psychology as pharmacology. Sarah Mitchell and James Carter examine the adherence crisis and what works.

Psoriasis Monitoring Landscape Guide
Monitoring for methotrexate-related liver toxicity dominated psoriasis practice for decades, but now the PIIINP blood test has replaced routine liver biopsies in most guidelines. Sarah Mitchell and James Carter walk through the current monitoring framework for systemic and biologic therapies in psoriasis.

Epigenetic Modifications Link Genes to Health Outcomes
Scientists link genetics to health through epigenetic modifications, specifically DNA methylation and histone deacetylases, influencing disease.

Patients Trust Google Over AI for Cancer Data, Doctors See AI Use for Patient Education
Patients prefer traditional search engines for health information, while physicians consider AI chatbots useful for patient education.

No Evidence Your Eyes Explain Overall Health in Recent Research
Recent research abstracts do not provide evidence linking ocular health to overall systemic health, focusing instead on unrelated topics.

Replacing Biologic Injections With Oral Pills
Deucravacitinib (the first approved TYK2 inhibitor) offers a new oral option for moderate-to-severe psoriasis without the cardiovascular safety concerns attached to pan-JAK inhibitors. Sarah Mitchell and James Carter examine how the oral therapy landscape is evolving and what it means for patients who refuse injections.

Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
A new study presented at ASCO 2026 demonstrates yoga significantly improves insomnia, fatigue, and anxiety in cancer survivors.

Doctor Attrition Linked to Moral Injury and Systemic Pressures
Dedicated doctors are leaving medicine due to moral injury from systemic pressures, impacting patient care and workforce stability.

Unilateral Strength Training Offers Distinct Advantages for GPs
Unilateral strength training addresses bilateral deficits, enhances stability, and can aid rehabilitation, offering distinct advantages over bilateral methods.

Surgery Linked to Slight Cognitive Decline in Older Adults
Older adults undergoing surgery may experience a small but measurable decline in cognitive function, warranting careful preoperative assessment.

Tricuspid Valve Surgery Benefits Adults with Systemic Right Ventricle
Adults with transposition of the great arteries (TGA) and systemic morphologic right ventricle (SRV) often develop SRV failure and tricuspid regurgitation (TR). A new study investigates the impact of tricuspid valve surgery (TVS) on clinical outcomes in this population.

Top Three Treatments for Eosinophilic Esophagitis Dysphagia Relief
Proton pump inhibitors, topical corticosteroids, and dietary elimination are primary treatments for EoE dysphagia, targeting inflammation and symptoms.

Dual Plane Block May Cut Opioid Use After Bypass Surgery
A dual plane block technique for coronary artery bypass grafting (CABG) may reduce postoperative opioid consumption.

Biologics Offer Targeted Efficacy in Psoriasis Management
Biologic therapies have significantly advanced psoriasis treatment by targeting specific immune pathways, offering improved outcomes for patients.

Physician Grief Post-Op Death: A Clinical Reality
Physicians experience significant grief following patient death, impacting well-being and professional practice. Acknowledging this reality is crucial.

Heimlich Maneuver: When and How to Perform for Choking
The Heimlich maneuver is a critical first-aid intervention for choking. Understanding its indications and proper technique is essential for all clinicians.

Four Lifestyle Factors Add a Year to Life Expectancy
Adopting four fundamental lifestyle habits can extend life expectancy by approximately one year, offering a clear, actionable pathway for patients.

Colonoscopy Beyond 75: Risks May Outweigh Benefits for Average-Risk Patients
The utility of routine colonoscopy in individuals over 75 years warrants re-evaluation due to increased procedural risks and diminishing benefits.

CAR T-Cell Therapy Shows Efficacy in Refractory Autoimmune Disease
CAR T-cell therapy, traditionally for cancer, demonstrates potential in severe autoimmune conditions, offering a new therapeutic avenue.

Antihypertensive Use Linked to Higher Fall Risk Across Patient Groups
Antihypertensive medications are associated with an increased fall risk across various patient demographics, necessitating careful risk-benefit assessment.

Tree Nut Allergy Prevalence in Dutch Children: A Review
A review of established medical knowledge indicates that tree nut allergies are a significant concern in pediatric populations, necessitating precise diagnostic and management strategies.

Patient Trust in Doctor Advice Declines: Survey Highlights Concerns
A recent survey indicates a decline in patient trust regarding medical advice, with implications for adherence and health outcomes.

Genital Lesions Most Common Sign of Chronic Candidiasis
Genital lesions are the most frequently observed clinical manifestation of chronic candidiasis disease (CCD), requiring careful differential diagnosis.

Myasthenia Gravis in Pregnancy: Exacerbations Common in Peripartum
Myasthenia gravis (MG) in pregnancy presents diagnostic and management challenges, with exacerbations common in the first trimester and postpartum period.

mRNA Shot Shows Efficacy Against Influenza-Like Illness
An mRNA vaccine demonstrated efficacy against influenza-like illness, offering a potential new approach to seasonal respiratory virus prevention.

Alternaria Allergy in Youth Signals Persistent Asthma Risk
Early sensitization to Alternaria alternata in children and adolescents is a significant predictor of asthma persistence into adulthood.

FDA Approves OTC Switch for Topical Adapalene 0.1% Gel
The FDA has approved the first over-the-counter retinoid, adapalene 0.1% gel, for acne treatment, expanding access to a previously prescription-only therapy.

Cataract Surgery: 4 Underappreciated Clinical Considerations
Cataract surgery, while common, presents nuances often overlooked in routine practice. This article details four less-known aspects.

COVID Not Primary Driver of Pediatric Type 1 Diabetes Rise
Evidence suggests the observed increase in pediatric type 1 diabetes predates the COVID-19 pandemic, indicating other factors are at play.

PAHO's HEARTS 2.0 Outlines 38-Step Pathway for Cardio-Renal Care
The PAHO HEARTS 2.0 initiative provides a 38-step pathway for integrated cardio-renal care, addressing the complex interplay of cardiovascular and kidney diseases.

ASCO 2026: Anticipating Advances in Oncology Treatment
ASCO 2026 is expected to highlight progress in targeted therapies, immunotherapy, and precision oncology, with a focus on biomarker-driven treatment strategies.

EASL Congress 2026: Key Trials to Watch in Liver Disease Management
EASL Congress 2026 will feature pivotal trials in NAFLD/NASH, HBV, and HCC, potentially reshaping current treatment paradigms.

CGRP Inhibitors for Migraine: CV Safety Data Limited in High-Risk Patients
CGRP-targeted therapies are effective for migraine prevention, but cardiovascular safety data is limited in patients with established vascular disease.

Ebola Pandemic Risk in 2026: A Low Probability Assessment
An Ebola pandemic in 2026 is considered unlikely due to established public health responses, vaccine availability, and improved surveillance.

ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
ATS 2026 highlights advancements in nontuberculous mycobacteria (NTM) lung disease, focusing on improved detection, optimized therapy, and patient quality of life.

Tirzepatide: Efficacy in Weight Management Explored at ATS 2026
Tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrates significant efficacy in chronic weight management, offering a new therapeutic option.

BRINSUPRI® First Therapy Approved for NCFB at ATS 2026
BRINSUPRI® receives first approval for non-cystic fibrosis bronchiectasis (NCFB), addressing a significant unmet need in chronic respiratory care.

Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
ATS 2026 highlighted epithelial cytokine pathways as a common link in severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and COPD.

Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use
New real-world evidence presented at ATS 2026 indicates that initiating triple therapy earlier in asthma management may improve patient outcomes.

YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
YUTREPIA® (treprostinil) inhalation powder offers a new prostacyclin treatment option for pulmonary hypertension associated with interstitial lung disease (PH-ILD).

IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
New insights from ATS 2026 reveal significant discrepancies between patient experiences and pulmonologist perceptions in IPF and PPF management.

AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma
Alpha-1 antitrypsin (AAT) protein extends its protective role beyond established AAT deficiency, influencing general lung health.

Epithelial Dysfunction: A Unified Target in Airway Disease Management
ATS 2026 highlights epithelial dysfunction as a central mechanism in upper and lower airway inflammation, informing evolving management strategies.

Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
Managing hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic and therapeutic challenges.

AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data
AIRSUPRA® (albuterol/budesonide) demonstrated a reduction in asthma exacerbations, addressing the need for improved rescue therapy.

IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction
IL-33 acts as both a pro-inflammatory cytokine and a contributor to mucus hypersecretion in COPD, complicating therapeutic targeting.

Triple Therapy Optimises COPD Outcomes at ATS 2026
ATS 2026 presentations highlight tailored triple therapy for obstructive lung disease, improving lung function and reducing exacerbations.

Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026
ATS 2026 discussions on severe asthma treatment highlight the need to integrate patient-reported outcomes beyond lung function, addressing quality of life.

AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints
Advancements in Alpha-1 Antitrypsin Deficiency (AATD) focus on restoring AAT levels and achieving clinically meaningful endpoints.

New Biologic Offers Option for Severe Eosinophilic Asthma
A new biologic agent presented at ATS 2026 provides an additional treatment option for patients with severe eosinophilic asthma.

ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease
ATS 2026 highlights the persistent gap in objective cough assessment in respiratory diseases, hindering precise diagnosis and treatment efficacy.

IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
An adaptive clinical study programme for IKT-001 in Pulmonary Arterial Hypertension (PAH) was presented at ATS 2026, detailing a novel approach to trial design.

Pediatric Pulmonary Research Gaps Highlighted for Global Health
A review of pediatric pulmonary research emphasizes significant disparities in global health and underserved populations, underscoring critical unmet needs.

AI Algorithms Enhance Pulmonary Disease Management at ATS 2026
Artificial intelligence applications in pulmonary medicine, presented at ATS 2026, demonstrate utility in diagnosis, prognosis, and treatment optimization.

Immunological Insights Inform ILD & Transplant Outcomes
New immunological insights presented at ATS 2026 clarify mechanisms of interstitial lung disease progression and allograft rejection post-transplant.

AI, Wearables Transform Sleep Diagnostics: ATS 2026 Preview
Next-generation sleep diagnostics, integrating AI, wearables, and sensors, promise to redefine the care continuum for sleep disorders, moving beyond traditional polysomnography.

Contagion: Acute Respiratory Failure Cases Highlight Ventilator Management
Case reports from ATS 2026 detail acute respiratory failure and immune-mediated lung disease, emphasizing ventilator and extracorporeal support.

Acute Respiratory Failure: Lifespan Phenotypes and Trajectories
Acute respiratory failure (ARF) presents distinct physiological phenotypes and trajectories across pediatric and adult populations, necessitating age-specific management.

Ventilator Management: Foundations for Bedside Implementation
Effective mechanical ventilation requires precise setup and liberation strategies. Practical foundations are essential for optimal patient outcomes.

Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
ATS 2026 session addresses persistent challenges in right heart catheterization waveform interpretation, offering a structured approach to reduce diagnostic ambiguity.

Pediatric Advanced Bronchoscopy: Precision in Airway Management
Advanced diagnostic and interventional bronchoscopy in pediatric patients offers precise airway management for complex conditions, reducing morbidity.

ILD Diagnosis and Management: A Practical ATS 2026 Update
ATS 2026 provided a practical framework for interstitial lung disease (ILD) diagnosis and management, emphasising multidisciplinary team approaches and early antifibrotic initiation.

Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances
ATS 2026 highlights mechanistic and multimodal approaches to obstructive sleep apnea, moving beyond CPAP to targeted therapies.

CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026
Cardiopulmonary exercise testing (CPET) continues to evolve, offering enhanced diagnostic and prognostic precision for various cardiopulmonary conditions. New applications presented at ATS 2026 highlight its utility beyond traditional indications.

Sarcoidosis: Current Understanding of Diagnosis and Management
Sarcoidosis presents a diagnostic and therapeutic challenge. This review summarises current approaches to diagnosis, staging, and treatment strategies.

ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management
ATS 2026 discussions focused on the complex etiologies and management of bronchiectasis and NTM pulmonary disease, highlighting updated guideline recommendations.

ATS 2026: Lung Cancer Management Advances in Targeted Therapy
ATS 2026 highlights evolving lung cancer management, focusing on precision medicine and novel targeted therapies for improved patient outcomes.

ATS 2026: Ultrasound Education Advances for Clinical Practice
ATS 2026 highlights advancements in ultrasound practice and instruction, addressing variability in operator proficiency and diagnostic accuracy.

Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques
ATS 2026 will feature a hands-on guide to basic bronchoscopy, EBUS, and guided bronchoscopy, addressing the need for advanced procedural competency.

MAVEs Inform Variant Interpretation in Clinical Oncology Practice
Multiplex Assays of Variant Effects (MAVEs) offer a systematic approach to interpreting genetic variants in oncology, addressing current limitations in variant classification.

AI in Oncology: Practical Applications Transforming Cancer Care
AI integration in oncology is moving beyond theoretical promise to deliver tangible benefits in diagnosis, treatment planning, and patient management.

DNA Methylation Patterns Emerge as Sarcoma Biomarkers
Sarcomas present diagnostic and therapeutic challenges due to their heterogeneous nature. DNA methylation profiling may enhance early diagnosis and personalized treatment.

HTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
Understanding tumor evolution is critical for effective cancer therapy. The Human Tumor Atlas Network (HTAN) provides an ecological and evolutionary framework.

Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
Extracellular vesicles (EVs) and particles (EPs) offer new avenues for cancer diagnosis, prognosis, and therapy. Their role as biomarkers and drug delivery systems is expanding.

NK Cell Immunotherapy: Biology to Clinic at AACR 2026
Natural killer (NK) cell-based immunotherapies are emerging as a promising cancer treatment strategy, with ongoing clinical trials exploring their efficacy.

Primary LV Unloading in Anterior STEMI Shows No Benefit in STEMI-Door to Unload Trial
The STEMI-Door to Unload trial found no benefit for primary left ventricular unloading in anterior STEMI without cardiogenic shock.

DISCOVER INOCA Defines Vasomotor Disorders in Nonobstructive CAD
The DISCOVER INOCA registry provides a comprehensive definition of coronary vasomotor disorders in patients with ischemia and nonobstructive coronary arteries (INOCA).

Sex Differences in MINOCA Causes Identified by OCT and CMR Imaging
OCT and CMR imaging reveal distinct sex-specific underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).

ORBITA-CTO: CTO PCI Offers No Angina Relief Over Placebo
The ORBITA-CTO trial found no significant difference in angina symptom improvement between CTO PCI and a placebo procedure.

FFR or 3D-QCA Guided Revascularisation: The FAST III Trial
The FAST III trial, reported at ACC.26, investigated revascularisation guided by FFR versus 3D-QCA-based vessel-FFR.

SURVIV: Transcatheter Valve-in-Valve Non-Inferior to Redo-Surgery for Mitral Bioprosthetic Dysfunction
The SURVIV trial found transcatheter mitral valve-in-valve implantation non-inferior to redo-surgery for bioprosthetic dysfunction, with similar 1-year mortality.

PRO-TAVI: Deferring PCI Before TAVI Non-Inferior to Routine PCI
The PRO-TAVI trial demonstrated that deferring percutaneous coronary intervention (PCI) before transcatheter aortic valve implantation (TAVI) is non-inferior to routine PCI.

Emboliner Non-Inferior to Sentinel for TAVR Cerebral Protection
ACC.26 trial shows Emboliner embolic protection catheter is non-inferior to Sentinel system during TAVR for preventing cerebral lesions.

Reverse-FALLS Protocol Reduces Pulmonary Congestion in CPE Patients
A prospective observational study demonstrated that the Reverse-FALLS protocol effectively reduced pulmonary congestion in patients with cardiogenic pulmonary edema.

IVUS Guidance Improves PCI Outcomes in Complex Bifurcation Lesions
Intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) in complex bifurcation lesions demonstrated superior outcomes compared to angiography guidance.

HOST-EXAM: Clopidogrel Monotherapy Non-Inferior to Aspirin at 10 Years
The HOST-EXAM trial's 10-year follow-up indicates clopidogrel monotherapy is non-inferior to aspirin monotherapy in stable CAD post-PCI with DES.

CHIP-BCIS3: LV Unloading Trial for High-Risk PCI
The CHIP-BCIS3 trial investigated percutaneous left ventricular unloading during high-risk coronary intervention, addressing a critical gap in managing complex PCI patients.

TRI-FR Trial: Tricuspid Repair Sustains Benefit at Two Years
Two-year outcomes from the TRI-FR trial demonstrate sustained efficacy of transcatheter tricuspid repair without cross-over for severe tricuspid regurgitation.

IVUS-Guided PCI Reduces MACE in Left Main Disease: OPTIMAL Trial
The OPTIMAL trial demonstrates IVUS-guided PCI significantly reduces major adverse cardiac events compared to angiography-guided PCI in unprotected left main coronary artery disease.

CHAMPION-AF: LAA Closure Non-Inferior to OAC for AF Outcomes
The CHAMPION-AF trial demonstrates left atrial appendage closure is non-inferior to oral anticoagulation for composite thrombotic and bleeding events in atrial fibrillation.

ALL-RISE: Angiography-Derived Physiology Non-Inferior to Pressure Wire for PCI
The ALL-RISE trial demonstrates non-inferiority of angiography-derived coronary physiology compared to invasive pressure wire guidance for PCI outcomes.

TRISCEND II: Transcatheter Tricuspid Valve Replacement Two-Year Outcomes
Two-year data from TRISCEND II show sustained improvements in severe tricuspid regurgitation with transcatheter valve replacement.

Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
EASL 2026 Skills Learning Centre will address variceal bleeding, highlighting current evidence for endoscopic and pharmacological interventions.

EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026 will feature a Skills Learning Centre on liver and spleen elastography, highlighting its role in non-invasive fibrosis assessment.

EASL 2026 Forum: Enhancing Patient-Clinician Communication
The EASL 2026 Patient & Advocate Forum addresses critical gaps in patient-clinician communication and interprofessional collaboration.

EASL 2026: Alcohol Policy Action Needed for Liver Disease
The European Health Alliance on Alcohol advocates for policy changes to mitigate alcohol-related liver disease, emphasizing the gap between clinical evidence and public health action.

A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
New A-TANGO organ failure score refines acute-on-chronic liver failure (ACLF) diagnosis and prognostication in hospitalised cirrhosis patients.

MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
Despite 2024 EASL guidelines for MASLD, physicians encounter significant barriers in screening and diagnosis, particularly in SEEMEA.

EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
EASL 2026 highlights the evolving role of non-invasive diagnostics in liver disease, offering improved accuracy for fibrosis and steatosis assessment.

Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
Late-onset genetic cholestatic diseases are frequently missed in adults, leading to delayed diagnosis and suboptimal management. Increased awareness is critical.

HDV Management: EASL 2026 Highlights PegIFN-α as Standard
EASL 2026 discussions reaffirmed peginterferon alfa as the cornerstone of HDV management, with emerging therapies showing promise.

MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
Experts at EASL 2026 discussed the distinct challenges of managing advanced fibrosis in MASH, highlighting diagnostic and therapeutic complexities.

EASL 2026 Consensus: AATD-Liver Disease Management Standardised
A new consensus statement from EASL 2026 aims to standardise the diagnosis and management of Alpha-1 Antitrypsin Deficiency (AATD) related liver disease.

EASL 2026: PSC Therapies Advance Beyond Symptom Management
EASL 2026 discussions highlighted progress in primary sclerosing cholangitis (PSC) treatment, moving from symptom control to disease modification.

MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
EASL 2026 data indicates non-invasive markers may reduce liver biopsy necessity for MASH diagnosis, offering a less burdensome alternative.

PARP1 Deficiency Reduces Amyloid Pathology in Familial AD Model
New preclinical work links PARP1 deficiency to reduced amyloid burden and cognitive preservation in a familial Alzheimer's model.

Early Breast Cancer at ASCO 2026: Trials to Watch
ASCO 2026 is expected to bring pivotal data on adjuvant and neoadjuvant strategies in early breast cancer. Here is what clinicians should watch for.

Lower-Dose Tirzepatide: Can It Sustain Weight Loss Long-Term?
New evidence examines whether reduced tirzepatide doses can maintain weight loss, with implications for long-term obesity management in primary care.

Few Pediatric Cancer Drugs Reach Phase 3 or Approval
The pipeline for pediatric oncology drugs remains sparse, with most candidates failing to progress beyond early-phase trials to approval.

Abdominal Obesity Linked to More Severe Menopause Symptoms
Women with central adiposity report more frequent and severe vasomotor and psychological menopause symptoms, with waist circumference emerging as a key clinical marker.

Oral Orforglipron Sustains Weight Loss After Injectable GLP-1 Therapy
The ATTAIN-MAINTAIN trial shows oral orforglipron preserves most injectable-achieved weight loss at 52 weeks, offering a scalable transition option.

Gut Microbiota Signal the Brain via the Vagus Nerve: What GPs Should Know
The gut-brain axis operates partly through vagal afferent neurons. Here is what the established mechanistic evidence means for everyday practice.

HRT and Cancer Risk: How the WHI Study Misled a Generation
The Women's Health Initiative's 2002 findings on HRT were widely misapplied. Reassessment of the data changes the risk calculus for most women.

Does Vaping Cause Cancer? What the 2025–26 Evidence Shows
Three new papers assess carcinogenicity, toxicant exposure, and oral microbiota changes in vapers. The evidence is concerning but incomplete.

Low-Dose Lithium for Cognitive Decline: What the Evidence Actually Shows
Lithium at sub-therapeutic doses has been studied as a neuroprotective agent in dementia prevention, but the clinical evidence remains thin and inconsistent.

GLP-1 Drugs and Oral Medication Absorption: What Prescribers Need to Know
GLP-1 receptor agonists slow gastric emptying, raising theoretical concerns about altered absorption of time-sensitive oral drugs. Evidence remains thin.

Hantavirus: Lethality, Transmission and What GPs Need to Know
Hantavirus carries case fatality rates up to 40% in some syndromes. Here is what clinicians and the public genuinely need to worry about.

SGLT2 Inhibitors and Ferroptosis: A New Mechanistic Picture in HF
Emerging evidence links SGLT2 inhibitors' cardiac benefit to ferroptosis suppression, offering a potential mechanistic explanation for their efficacy in heart failure.

2025 AHA/ACC Hypertension Guidelines: What GPs Need Now
The 2025 AHA/ACC hypertension guidelines update prescribing priorities. Here is what the evidence says about antihypertensive management today.

Cephalosporin Prescribing Falls Short of Guidelines in Tertiary Care
New prospective data from South India and South Africa expose persistent gaps in cephalosporin appropriateness, de-escalation, and resistance-informed prescribing.

Dupilumab in Severe Asthma: Real-World Cohort Data Begin to Arrive
Dupilumab and other biologics for severe type 2 asthma show real-world promise, according to three new studies.

JAK Inhibitors in RA: 2025 EULAR Safety Update Redraws Risk Guidance
EULAR's 2025 update to rheumatoid arthritis guidance tightens JAK inhibitor safety rules, affecting prescribing for higher-risk patients.

Parkinson's Neuroprotection 2025: Three Strategies Under Review
Stem cell therapy, System Xc- pathway modulation, and Ayurvedic add-on regimens are under evaluation as neuroprotective strategies for Parkinson's disease.

ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits Now
Three 2026 reviews show ctDNA liquid biopsy in CRC detection and monitoring lags in clinical integration despite growing evidence.

PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known Atherosclerosis
Evolocumab's use in diabetic patients without atherosclerosis is tested in VESALIUS-CV. Other trials investigate plaque biology and lipid pathways beyond LDL.

Perilla Oil Nanoemulsion Improves Psoriasis Scores in Mouse Model
A perilla essential oil nanoemulsion reduced erythema, scaling, and inflammatory markers in imiquimod-induced psoriasis, with curcumin co-loading enhancing skin permeation.

SGLT2 Inhibitors Post-Heart Transplant: What the Data Show
A 2026 meta-analysis explores SGLT2 inhibitor use in diabetic heart transplant recipients, a high-stakes, evidence-thin population.

Addiction Recovery: A Canadian Perspective on a Global Crisis
Canada's addiction psychiatry academy calls for urgent, enhanced mental health and addiction treatment services post-COVID, offering a framework for other nations. But can it scale?

What Still Eludes Us in MASH Research?
MASH (metabolic dysfunction-associated steatohepatitis) is a complex disease, and while we've made strides, key mechanistic details remain elusive. This demands a sharper focus on translational studies that can directly inform clinical practice.

Extended Reality for Congenital Heart Defect Education
Extended reality (XR) could improve understanding and surgical planning for congenital heart defects (CHDs), aiding families and trainees alike.

Does Vitamin D Improve Outcomes in Orthopedic Trauma?
Vitamin D's role in orthopedic trauma remains murky. No clear evidence supports supplementation for faster fracture healing or lower infection risk.

Health Literacy and Lung Cancer Diagnostic Delays
Limited <a href="https://thelifesciencefeed.com/keywords/health-literacy">health literacy</a> means significant lung cancer diagnostic delays, worsening health inequities and burdening healthcare.

Lorlatinib and New-Onset Diabetes Practical Monitoring for Oncologists
Lorlatinib demands vigilant monitoring for hyperglycemia and ketoacidosis. Proactive screening and early intervention are crucial for patient safety.

Lorlatinib and the Enigma of Autoantibody-Negative Diabetes
Lorlatinib can cause autoantibody-negative diabetes. This presents a diagnostic challenge, requiring clinicians to consider drug-induced causes even with negative immune markers.

Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?
Growth charts tailored for Alagille Syndrome (ALGS) could refine the assessment of malnutrition in these children, but questions remain about their broad applicability. Clinicians should view these new charts cautiously, considering the limitations of the underlying data and the potential for misinterpretation.

Hemophilia Normalization's Price Tag and Policy Implications
Achieving 'normalization' in hemophilia care, while improving patient outcomes, introduces substantial financial burdens on healthcare systems. Payers must grapple with the high costs of novel therapies and ensure equitable access.

Health Literacy Gaps and Lung Cancer Diagnosis: A Policy Perspective
Patients with low health literacy and chronic conditions face significant delays in lung cancer diagnosis, impacting survival. Health systems must address these disparities through targeted interventions and policy changes to improve early detection and outcomes.

Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic Challenge
Atrial fibrillation patients face complex cardio-kidney-metabolic risks, demanding integrated care. Policy and reimbursement hurdles complicate CKM clinic establishment.

Unraveling MASH: Implications for Clinical Practice
A review in Nature Reviews Gastroenterology & Hepatology clarifies MASH's complex interplay of metabolism, inflammation, and fibrosis, offering practical guidance for risk stratification and patient management.

Atrial Fibrillation Complexity: How Reliable is Registry Data?
Patients with atrial fibrillation often present with a complex interplay of cardio-kidney-metabolic conditions, but large registry data can oversimplify these interactions. Clinicians should interpret such observational findings cautiously, especially when considering individual patient management.

ECPR Rewarming: A Case for Prolonged Resuscitation?
A case report suggests prolonged ECPR for severely hypothermic patients with cardiac arrest and coagulopathy can lead to full neurological recovery.